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ABSTRACT 
Meningitis is the inflammation of the lining membranes of human brains and spinal cord. 
It is a deadly disease that has claimed millions of lives throughout the world in particular 
in developing countries. Neisseria meningitidis serogroup A is among the leading 
causative agents of meningitis in Sub-Saharan Africa. Its capsular polysaccharide 
antigen consists of a homopolymer of a-(1 ~6) linked mannosamine phosphate residues. 
So far, no vaccine of high efficacy to prevent the most affected age groups (infants) has 
been licensed against meningitis caused by serogroup A. The low efficacy of the vaccines 
tested is attributed to the instability of the phosphodiester glycosidic bond of the antigen 
towards acids. In the hope that substituents different to that of the C-2 N-acetyl group in 
the native mannosamine monomer may stabilise the glycosidic bond, we have evaluated 
different ways of synthesising key building blocks for preparation of novel stabilised 
glycoconjugates as vaccine candidates. 
Three key intermediates in the preparation of desired oligosaccharide conjugates were 
identified and various synthetic routes to these evaluated. These intermediates were 2-
azido-2-deoxY-D-mannopyranose, a suitably protected derivative of this azidomannose 
with selectively removable group at 0-6, and an u-2-azido-D-mannopyranosyl-
hydrogenphosphonate derivative as precursor to the oligomer or polymer. The first 
intermediate was obtained either via azidonitration of protected glucal or by SN2 
displacement by azide ion of suitably protected 2-0-triflylglucoside followed by de-O-
acetylation. The selectively protected intermediate was synthesised making use of the 
formation and subsequent regioselective opening of 4,6-0-benzylidene acetals derived 
from the first key intermediate. Formation of the anomeric hydrophosphonate from this 
second intermediate was achieved with salicylchlorophosphite to give selectively the u-
anomer of 2-deoxy-2-azidomannopyranosyl-hydrophosphonate. 
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1. INTRODUCTION 
1.1 MENINGITIS 
Meningitis is a disease that exclusively attacks human beings. It is an infection of the 
fluid that surrounds the brain and spinal cord. It is usually caused by a bacterial or viral 
infection.! The severity of the illness depends on the disease-causing agent. 
1.1.1 Viral Meningitis 
Viral meningitis is generally relatively less severe. It resolves in a week or two without 
intervention of any specific treatment. No specific kind of virus has been linked with the 
disease and, thus, any of a number of different viruses and mainly the entero (intestinal), 
varicella, the mumps and adenoviruses could be responsible for viral meningitis.2 Viral 
meningitis is spread by person-to-person contact or by insects like mosquito depending 
on the virus involved. Diagnosis of the disease is by blood tests, however, no specific 
vaccine treatment is available. An outbreak of viral meningitis is rare and occurs as a 
single event. Taking good care of personal hygiene and avoiding mosquito bites help 
prevent contracting the disease.3 
1.1.2 Bacterial Meningitis 
Bacterial meningitis, mostly caused by invasive Haemophilus injluenzae (Hib), 
Streptococcus pneumoniae (Pn), and Neisseria meningitides (Mn), is one of the top ten 
infectious causes of death globally.4 According to the World Health Organization (WHO) 
report in the year 2000, bacterial meningitis was found to be responsible for an estimated 
171,000 deaths worldwide per annum. Prior to the 1990s, Haemophilus injluenzae type b 
was the leading cause of bacterial meningitis, but with the introduction of glycoconjugate 
vaccines invasive disease due to Haemophilus injluenzae has reduced. In the same 
fashion, meningitis caused by Streptococcus pneumonia and certain serogroups of 
Neisseria meningitides have been eliminated significantly.4 Today, a few types of 
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are the leading causes of bacterial meningitis throughout the world but more 
pronounced in developing countries.5 Thus, understanding the microbiologic features 
of Neisseria meningitides and their entry into the bloodstream and cerebrospinal fluid 
is very important in order to understand the virulence of the disease and how to 
combat it. 
1.2 MICROBIOLOGIC FEATURES OF NEISSERIA MENINGITIDES 
Neisseria meningitides is the leading cause of meningitis among other agents and 
causes endemic and epidemic diseases mostly in developing countries. Neisseria 
meningitides is an aerobic gram-negative spherical or kidney shaped diplococcus 
(bacilli) commonly found in pairs intracellularly (Fig. 1). Human beings are their 
exclusive natural hosts. The structure of the bacterium consists of outer and inner 
(cytoplasmic) layers that are separated by a peptidoglycan cell wall (Fig. 2).6 
Fig. 1 Neisseria meningitides (Arrow) in Cerebrospinal Fluid (Gram's stain, x 1000).7 
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Fig. 2 Cross-Sectional View of the Meningococcal Cell Membrane.? 
The outer layer of the bacteria consists of: 
i. Capsular polysaccharides 
3 
The capsular polysaccharides are found at the outer cell membrane of the organism. 
Though the polysaccharides are not toxic by themselves, they are mainly engaged in 
the protective mechanism ofthe organism against dehydration and the human immune 
system by inhibiting phagocytosis. And hence, it enhances the survival of the 
organism during invasion of host cells.5 
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ii. Pili 
Pili are organells of complex proteins that are found on the outer membrane of the 
meningococci.5 On the basis of serology and structure, pili are classified into two classes 
namely, class I and class II pili. Both classes belong to type IV pili as they are members 
of the methylphenylalanine pili family.s Besides their assistance in adherence to host 
cells, pili are essential in genetic competence and twitching motility of the organism 
during invasion of host cells. 5 (explained more in pathogenesis). 
iii. Lipopoly( oligo )saccharide5 
Lipooligosaccharide (LOS or endotoxin) and lipopolysaccharide (LPS) are also parts of 
the outer membrane of the meningococci a bacteria. LOS and LPS are structurally related 
except that LOS lacks a repeating unit of a-antigen. The conserved inner core of both 
LOS and LPS is composed of heptose and 3-deoxy-D-manno-2-octulosonic acid (KDO) 
attached to a lipid A moiety embedded in the outer membrane. A more variable sequence 
of sugar residues composed of glucose, galactose, N-acetylglucosamine, and 
N-acetylneuraminic acid (NANA) is attached to the inner core heptoses. Two short 
oligosaccharide chains that have variable composition are attached to the two inner core 
heptose residues in meningococcal LOS. The variable composition of the 
oligosaccharides functions as a basis for immunotyping meningococcal strains. The 
lipopolysaccharide (endotoxin) is involved in pathogenesis as it confers serum resistance. 
iv. Outer membrane proteins (aMP) 
The outer membrane of Neisseria meningitides contains a number of protein structures 
along with the other mentioned structures. The two major porins of the bacteria are PorA 
and PorE. PorA is frequently recognized by the host cells and helps the meningococci to 
interact with the cells. PorB, on the other hand, has the ability to insert into membranes of 
host cells and thus facilitates adherence to and invasion of the cells by the bacteria. The 
outer membrane also contains other proteins that are important in pathogenesis and 
adherence to host cells.5,6 
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1.3 NEISSERIA .MENINGITIDES SEROGROUPS 
In the case of bacterial meningitis, it is important to know which type of bacteria is 
causing the disease, as the available treatments are specific to certain types of bacteria. 
Meningococci are classified by serologic typing systems into different categories, On the 
basis of immune specificity of the capsule, Neisseria meningitides are classified into 13 
serogroups CA, B, C, D, H, I, K, L, W135, X, Y, Z, and 29E).9 Meningococci are also 
further classified depending on antigenic differences in their major outer membrane 
proteins PorB into serotype, other outer membrane proteins PorA into serosubtype, and 
the structure of the outer membrane lipopolysaccharide into immunotype,lO 
Studies have shown that most of the meningococcal diseases are caused by serogroups A, 
B, C, WI and Y, Serogroups B, C, W13S, and Y all contain sialic acid (N-
acetylneuramic acid, NANA), whereas serogroup A is composed of repeating units of a-
linked N-acetylmannosamine-l-phosphate. Reports have indicated that the average chain 
length and molecular weight of serogroup A are 93 residues and in excess of 100,000, 
respectively,]] Although the structures of serogroups B and Care homopolymers of sialic 
acid, their structures differ at the glycosidic linkage of each monomer (unit). In serogroup 
B the units are linked a2-48 whereas in the case of serogroup C, the linkage is usually 
a2-49. Serogroup Y is composed of an alternating sequence of D-glucopyranose and 
partially O-acetylated NANA. The W135 serogroup differs from Y in that it contains an 
alternating sequence ofD-galactose and NANA. 1l,i2,13 
Mn A: -46ManNac(30Ac)a 1-40P03-4 
MnB: -48NeuSAca2-4 
MnC: -49NeuSAc(7/80Ac)a2-4 
Mn WI3S: -46Glcal-44NeuSAc(OAc)a2-4 
MnY: -46Galal-44NeuSAc(OAc)a2-4 
Figure 3. Structures of repeating units of Neisseria meningitides serogroups A, B, C, 
W13S, and Y,30.36 
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1.4 lYIENINGOCOCCAL EPIDEMIOLOGY 
A, Band C are responsible for 90 % cases of the epidemics. Serogroup A accounts for 
most of the epidemics around the world particularly in the developing countries like the 
sub-Saharan Africa, Pakistan, Nepal, Bhutan and parts of India.6,14,15 The region that 
extends from Senegal through Gambia from the west to Ethiopia in the east is recognized 
as the African meningitis belt. In the meningitis belt, serogroup A has been responsible 
for meningococcal epidemics for more than a century. Over 300,000 cases and 30,000 
deaths were reported in the 1996-97 meningococcal epidemic outbreak in the region. 16 
The epidemic occurs irregularly in 0 year cycles exclusively during dry seasons 
between November and April. The data reported by Communicable Disease Surveilance 
and Response (CSR) of the WHO further elaborates on the severity of meningitis in the 
region. As of 9 March 2003, a total of 2,056 cases including 195 deaths were reported 
since the Mn A outbreak began in February 2003 in Niger. 17 Besides serogroup A, 
serogroup W135 associated with the Hajji (Umrah) pilgrimage in Saudi Arabia resulted 
in 53 % of cases of the epidemics in the region in 2000. Quite recently, as of 6 March 
2003 in one of the mostly affected country in the 'Meningitis Belt', Burkina Faso, 
suffered a total of 3,691 cases including 542 deaths since the outbreak began in January 
2003. Clinical results showed that Mn A and Mn W135 were responsible for the 
outbreak. 18 
Serogroup Band C are prevalent in Europe. 50 90 % of cases of meningococcal disease 
are attributed to serogroup B and the remainder to C. 18 High proportion of strain 
serogroup B is isolated in Norway, the Netherlands, Germany and Denmark. Whereas in 
Czech Republic, Slovakia, Grecee, Republic of Ireland, Spain, and the UK high 
proportion of strain serogroup C are isolated. In North America, most commonly isolated 
serogroups are then C, B, and y.18,19 
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1.5 :\1ENINGOCOCCAL PATHOGENESIS 
Neisseria meningitides is transmitted from person to person by direct contact with 
respiratory secretions or via inhalation of aerosols. The newly arrived organisms multiply 
and colonise the nasopharynx by binding to the non-ciliated epithelial cells with the help 
of pili and opacity-associated proteins.20,27 The epithelial cells engulf the attached 
organisms into the phagocytic vacuoles?O The IgA I protease and PorB enhance the 
survival of the organisms in the epithelial cells by cleaving lysosome-associated 
membrane protein and crossing the cell membrane, respectively.21 The organism can 
survive in the site without causing any epidemics resulting in a carrier state of the host, 
infact 5 to 10 % of adults are carriers of asymptomatic nasopharyngeal meningococci. As 
a result of the asymptomatic carriage, most carriers develop immunity to the bacterial 
antigens.s,22,23,24 For unknown reasons, in certain individuals of these asymptomatic 
carriers, the organisms traverse the epithelial surfaces of the respiratory tract and gain 
access to the bloodstream to cause meningococcal septicaemia. Unless prompt medical 
treatment takes place, the bacteria continue to colonize and damage the endothelial cells 
of brain microvessels. After damaging the celis, the bacteria cross the blood-brain barrier 
(BBB) to gain access to the cerebrospinal fluid (CSF) as shown in Figure 4 and thereby 
cause meningitis.5 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
.. 
.. 
o 
!! 
E 
1. , 
1 
-.:I 
o 
o 
iii 
"C 
'5 
I: 
ii 
c 
'a. 
e 
~ 
AttIOtmMntto and interaction with 
IlNOpbuyng ••• epithelium 
Survival in the bloodstream 
PasSlIge through the mucosa 
Factors altectlng Intravascular survival 
• Capsulo: 1'11>1«.1$ ;19,in., cornp"",,,,nl mcrii", 'cd 
b.1r.lcriolysir. ;):1<1 I''''.~<lcyl<l"is 
• Ac:qlrisiiian af iron from lri1nsfcrrin 
Endotoxin and other 
cell components 
InflmmmlllOlY C:Vloicine-s 
(lurnbr rn:orusi!O ro:K:l(lr II, 
il1l",I"u l«,··111. 6, 8\ 
Anti nllammalory cytolcln@s 
Iim",I.oki,,·10j 
Crossing of the blood-brain barrier 
8 
Figure 4. Colonization of Neisseria meningitides in the Nasopharynx and Entry into 
the 
Bloodstream and Cerebrospina Fluid.7 
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Meningococcal diseases are age-dependent. The incidence of the disease is highest 
among children between the age of 6 and 24 months and declines thereafter with age; but 
peaks among people in the range of 5-24 years. Children of less than 6 months of 
seem to be immunised; most likely due to the presence of maternal acquired 
antibodies (via placental or breast milk).6,25 Some of the factors that are associated with 
an increase in risk of developing meningococcal disease include: overcrowding, poverty, 
concurrent viral infections, both active and passive smoking, chronic underlying illness, 
alcohol consumption, complement deficiency (C3 and deficiency), 
hypogammaglobulinaemia, and hyposplenism.6,7 
1.6 MANIFESTATIONS OF MENINGITIS7,9,26 
The similarity of meningitis symptoms to some other less serious diseases makes 
diagnosis of meningitis difficult. Unless prompt medical treatment with antibiotics (like 
penicillin) is provided, the disease can cause death in a matter of hours. Hence, knowing 
the symptoms is very crucial in combating the disease. The symptoms include a sudden 
onset of severe headache, stiffness of the neck, dislike of bright lights, fever, nausea, 
vomiting, drowsiness, impaired consciousness, and rash. Though of the neck and 
photophobia (dislike of bright lights) are not common manifestations in infants and 
young children, they may also suffer from a tense or bulging fontanelle. There is no 
specific order by which the symptoms appear and also all of them mayor may not be 
noticed in individual patients. 
Some survivors of meningitis suffer from complications of the disease. The chanpe of 
contracting the aftereffects depends on the type and severity of the disease and several 
other factors. The complication may be permanent or temporary, physical or emotional. 
The common include: memory loss, clumsiness, residual headaches, hearing 
loss, learning difficulties, epilepsy, neurologic disability, speech problem, loss of sight, or 
loss of a limb. 
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Some of the emotional aftereffects include: clinginess, temper tantrums, moodiness or 
aggression, disturbed sleep, nightmares, bed-wetting, changes in character, learning 
difficulties, and depression. 
1.7 PREVENTION AND CONTROL 
1.7.1 Early Treatments of Meningitis 
Once the bacterium transfers from a carriage state to an invasive one, fatality of the host 
can result within 24 to 48 hours after the onset of symptoms if there is no immediate 
medical intervention. However, statistics have shown that with the introduction of 
antibiotics like penicillin or ampicillin with the ability to kill meningococcal bacteria in 
the blood and fluid around the brain, the mortality rate has decreased from 60 - 80 % to 
10 %?8 
Although early recognition of the signs and symptoms of the disease and rapid medical 
treatment with antibiotics improves the chances of recovery, the similarity of the 
manifestations with some other non-serious illnesses can delay early appropriate 
treatment. 
Different treatments of meningitis have been reported since the first description of 
meningococcal meningitis by Gaspared Vieusseux in Geneva in 1805.29 As the etiology 
agent was not yet known, scientists at that time put much emphasis on stomach and 
bowel evacuation as the sole means of treating meningitis,z9 Identification of 
meningococcus from CSF by Anton Weichselbaum in 1887 enabled establishment of a 
link between the disease and disease-causing agent as well as a better treatment. The 
finding thus shifted the emphasis to drainage of CSF by repeated lumbar punctures in the 
late 19th century?9 In early 1900s serogroups were identified and serum therapy was 
introduced by Flexner in 1913. The survival rate improved from 10 30 % to 69.1 % in 
1,294 cases.29 The discovery of the antibacterial activity of sulfonamides in the early 
1930s opened the gate for a new way of treating meningitis. Francis Schwentker et ai. 
were the first to report a cure of meningococcal meningitis with sulfanilamide therapy in 
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1937.9,29 Though the sulfonamide therapy improved survival from meningitis, 
development of sulfonamide resistant meningococcal put an end to sulfanilamide therapy 
in the early 1960s.9 The emergence of new antibiotic resistant strains and the delicacy of 
the cerebrospinal fluid membrane, left researchers with only one option, which is 
prevention to control the deadly disease. Hence, mass immunisation through vaccination 
was the best approach for the prevention of infection. 
1.7.2 Vaccines against Neisseria meningitides 
The history of vaccines against meningitis dates back to the early 1900s. The vaccines at 
that time were either heat-killed whole meningococci or crude extracts of broth cultures. 
However, such vaccinations resulted in adverse effects after injection and also variable 
efficacy. After isolation of purified capsular polysaccharides in 1935, the trial of purified 
serogroups A and C as vaccines by Kabat and co-workers, failed to induce antibody 
responses in human volunteers.6,3o The account on the failure given by the authors was 
that the techniques used for the isolation of the polysaccharide were susceptible to 
probable enzymatic degradation of the polysaccharide to low molecular weight 
oligosaccharides. Gotschlich and co-workers from the Walter Reed Army Institute of 
Research (USA) developed a technique for the isolation of highly purified high molecular 
weight meningococcal polysaccharide and the polysaccharides isolated induced antibody 
response in adult volunteers.6 The findings led to routine immunization with a divalent 
vaccine that contains serogroups A and C and a quadrivalent vaccine covering A, C, Y, 
and W135 since 1970s and 1982, respectively.6,3o Although the di-and quadrivalent 
vaccines are administerd as a single dose, antibody responses to each of the 
polysaccharides are serogroup specific and independent. Antibody response to the 
vaccine develops within 7 to 10 days after inj ection and depends on several factors 
including: mo lecular size of the antigen, dose of the vaccine, number of exposures to the 
vaccines, and age of the recipient. The effectiveness of the polysaccharide vaccines was 
proved in prevention of disease due to serogroup C in US military recruits and also in 
controlling group A epidemics during mass campaigns in African meningitis belt. A 
number of reports have described the vaccines as safe with generally mild side effects 
consisting of pain and redness at the site of injection. 6,9,30 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
- 12-
Reingold et al. reported that efficacy of serogroup A peaks to 90 % and 67 % for the first 
year of all children and 3 years in children over 4 years of age, respectively.31 
Immunogenecity studies further indicated that in infants of under 1 year of age, antibody 
levels decrease in less than 1 year and in less than 2 years for children in the age range of 
2-3 years old though high levels persist for more than 5 years in adults after a single 
vaccination. 30,32,33 These results demonstrated that infants under the age of 1 year old are 
at high risk of contracting meningitis. It has also been reported that repeated injections 
resulted in decreased immunogenecity of the subject. 
The limitations of most polysaccharide vaccines can be summarized as follows: 
• Multiple doses of vaccine are required since the antigens fail to induce 
immunological memory 
• Short duration and age dependency of immunity after a single dose, 
• The efficacy in very young children is limited. 
• They don't result in reduction of transmission of the disease in the population at 
risk (herd immunity). 
These inhibit the usefulness of the vaccines in preventing and controlling meningitis 
particularly in infants who have the highest risk of sporadic disease. 
The failure to induce an immunologic memory of a polysaccharide antigen is known to 
be due to T cell-independent response of short duration to the antigen.31 This failure has 
been solved to a certain extent in some cases of bacterial meningitis by implementing a 
polysaccharide-protein conjugate vaccines. Vaccines of such kind are known to be able to 
induce a T cell-dependent response. Conjugate vaccines against Haemophilus injluenzae 
type b27 and Neisseria meningitides serogroup C infections have been licensed for 
paediatric purposes.34,35,36, Recent reports indicate that, unlike polysaccharide vaccines, 
the vaccines induce immunological memory, elicit long-lasting protection and are 
immunogenic in very young children.37,38 However, studies have shown that vaccination 
of animals and humans with the derived conjugate vaccine against Neisseria meningitides 
serogroup A infections resulted in poor immunogenicity.39 As it has been mentioned 
earlier, the native antigen (capsular polysaccharide) of the Neisseria meningitides 
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serogroup A is a homopolymer of a(l ~6) linked N-acetylmannosamine phosphate. The 
glycosidic phosphodiester bond is sensitive to both acids and bases and this lability is 
thought to cause instability and thus poor immunogenicity of the Men A conjugate 
vaccine?9 
Further studies were carried on to improve the vaccines in preventing and controlling 
meningitis. Pozsgay et al. showed that a synthetic oligosaccharide protein conjugate 
vaccine for Shigella dysenteriae type 1 to be more immunogenic than a similar one 
prepared from a natural polysaccharide,zs Ali et al. have also stated that a synthetic 
polysaccharide protein conjugate vaccine for Haemophilus injluenzae type b elicits a 
higher immune response than the one made from natural polysaccharide.28 However, no 
effective conjugate vaccine of any type has been licenced against Neisseria meningitides 
serogroup A infections though it is responsible for 90 % of the cases of endemic and 
epidemic meningitis caused by Neisseria meningitides bacteria worldwide. 
Hence, on the basis of these findings, we set our objectives to synthesise novel stabilised 
synthetic capsular oligosaccharide of serogroup A, chemically conjugate it to a carrier 
protein and investigate the immunogenicity of the resulting glycoconjugates as vaccine 
candidates against Neisseria meningitides serogroup A infections. 
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2. RESULT AND DISCUSSION 
2.1 RETROSYNTHETIC ANALYSIS 
The meningococcal (Mn) group A organism responsible for 90 % of the cases of endemic 
and epidemic meningitis has a capsular polysaccharide antigen which is a homopolymer 
of a-(l ~6) linked N-acetyl-D-mannosamine phosphate 1. The objective of this project is 
to develop synthetic oligosaccharide conjugates related to this structure. However, since 
the mannosamine phosphate 1 is known to be acid-labile, the further intention was to 
prepare analogues with different substituents at C-2 of the mannose unit, which may help 
stabilize the glycosidic linkage. 
NHAc 
HO 
AcO-__ ~· 
1 
The initial synthetic targets were oligosaccharide conjugates depicted in structure 2. The 
formation of this disaccharide glycoside requires precursor hydrophosphonate 3 and 
glycoside 4 which are in turn obtained from the 2-azido-2-deoxY-D-mannose 5 as 
common building block. 2-Azido-2-deoxymannose 5 can be readily converted either to 
the hydrophosphonate 3 or, after suitable activation, such as through preparation of 
trichloroacetimidate 6, transformed to glycoside 4 which incorporates a function ali sed 
"linker" for later attachment to a protein. The protecting group R in Scheme 1 needs to be 
carefully chosen so that it may be selectively removed without, in particular, reducing the 
azide, to allow for further elongation of the oligosaccharide (Scheme 1). 
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AcO I 
O~NHZ 
AcO 
o 
II 
O-P-H 
@ Ie 
Et3NH 0 
3 
u 
~RO ~O AcO AcO ~ 
OR 
5 
< 
2 
u 
Scheme 1 
AcO 
AcO--\'''''''''~'''''' 
4 
u 
AcO 
6 
O~NHZ 
oyCC13 
NR 
The key intermediate 3,4-di-O-acetyl-2-azido-2-deoxY-D-mannose derivative 5 can be 
synthesized from 2-azido-2-deoxY-D-mannose 8 which in turn can be derived from either 
protected glucal 7 or selectively protected glucoside 9 (Scheme 2). 
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Aco~rl-o 
AcO 
...-: 
7 
RO N3 ACO~I-O\ 
ACO~ 
OH 
5 
u 
HO~~O\ 
HO~ 
8 
OH 
Scheme 2 
2.2 SYNTHESIS OF 2-AZIDO-2-DEOXYMANNOSE 8 
- 16-
Ph\~ o 0 
AcO 
OH 
OMe 
9 
The first key synthetic intermediate required in our study was 2-azido-2-deoxymannose 
8. The azide is a non-participating group in glycosidations and can be converted to the 
amine via mild reductions, although in our case, the azide will be retained. Although 
2-amino-2-deoxysugars are abundant in nature, the difficulty to separate them from 
natural sources limits their availability.40 Hence, a variety of different methods of 
introducing the azido functionality into sugar molecules have been reported, where the 
desired regio- and stereoselectivity depends upon reaction conditions, reagents, and 
precursors used. 
Widely used methods for introducing azides into sugars are: 
i. Azidonitration of glycals 
The use of glycals as precursors for the synthesis of 2-amino sugars was pioneered by 
Lemieux, who introduced the azidonitration process, where glycals are transformed to 2-
aminopyranosyl derivatives.41 In a typical example, treatment of galactal 10 with CAN 
and sodium azide in acetonitrile gave 2-azido-2-deoxyglycoses 11, 12 and 13, which 
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were further functionalised to provide glycosylacetate 15 and glycosylhalides 16, 17 and 
18 (Scheme 3). The shortcoming of this azidonitration procedure is the fact that mixtures 
of manno- and gluco diastereomers are obtained. When glucal is used as precursor, 
normally with the gluco diastereomer prepondering. 
OAc OAc A00-0° 
10 
15 
11 RI H, R2 = ONOz, R3 = H, N3 (8 %) 
{ 
12RI H, =ON02,R
3
=N3,R
4 H(22%n 
13 RI = ONOl , = H, R3 =N3' R4 = H (53 %)! 
~---------v~--------~ 
(i) CAN, sodium azide, CH3CN, 15°C. 
Scheme 3 
ii. Azido-phenylselenation 
OAc OAc 
A'O~ + 
16 X = CI (74 %) 
17X=Br(60%) 
18 X = I (crude) 
N3 i 
NHAc 
14(10%) 
This method is analogous to Lemieux's azidonitration. Two methods are reported for the 
synthesis of phenyl 2-azido-2-deoxy-a-D-selenoglycopyranosides from protected glycals 
by Czernecki et al .. 42 The first method involves treatment of a peracetylated glycal with 
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sodium azide and diphenyl diselenide in the presence of (diacetoxyiodo )benzene m 
dichloromethane at room temperature as exemplified in scheme 4. 
~ACO A~CO 0 AcO 0 A 0 ___ 1 ~ I --'--... " AcO 
c AcO 
N3 
SePh 
7 19 
A~CO N3 
_0 
AcO 
AcO 
SePh 
20 
(i) Diphenyl diselenide, sodium azide, (diacetoxyiodo)benzene, dichloromethane, RI, 
91 % (in a ratio of3:2). 
Scheme 4 
In the second method, a protected glycal is treated with trimethylsilyl azide and tetra-n-
butylammonium fluoride in the presence of N-phenylselenophthalimide. Both methods 
result in mixtures of gluco and manno isomers from protected D-glucals whereas a 
galactal gives exclusively the gal acto isomer. The former method is incompatible with 
benzyl ethers and acetals whereas the latter method is compatible with a variety of 
protecting groups including benzyl and silyl ethers as well as acetals.42 
iii. Electrophilic azidation 
Evans et al.43 showed that electrophilic azide transfer from arylsulfonyl azides to enolates 
was a practical approach to the asymmetric synthesis of a-amino acids.44 Later this 
approach was exploited for the synthesis of azidosugars. Following this protocol, the first 
practical synthesis of 2-azido-2-deoxY-D-mannono-1,5-lactone was achieved. Selective 
reduction of the lactone with DIBALH provided 2-azido-2-deoxyaldoses without 
epimerization at as exemplified in Scheme 5.40 
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21 Rl OBn,R2 =H 
25 R1 =H,R2 =OBn 
Rl OBn 
B~ 
22 Rl OBn, R2 = H (73 %) 
26 Rl H, R2 = OBn (79 %) 
o 
(i) KHMDS; (ii) Trisyl azide; (iii) AcOH; (iv) DIBALH. 
Scheme 5 
ii 
iv. Diazo transfer for the synthesis of azides from amines 
- 19-
Amines can be converted into azides by diazo transfer from TfN 3 under mild reaction 
conditions.45 D-Glucosamine, D-mannosamine, and D-galactosamine were transformed to 
their corresponding peracetylated 2-azido-2-deoxyaldoses in 91 %,65 %, and 70 % yield, 
respectively.46 It has been reported that the diazo transfer can be also catalyzed with the 
help of divalent metal cations like eu ++, N++ or Zn ++,47 The general reaction conditions 
are as outlined in Scheme 6: 
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29 
v. Iodoazidation 
MeOH,CuS04, 18-36 h 
2. AC20, Pyr, DMAP 
Scheme 6 
- 20-
n(ACO)~(N3)n 
30 
It is possible to introduce azides into glycals other than at the C-2 position. For example, 
1,2-trans-2-deoxy-2-iodoglycosyl azides were prepared from the reaction of glycals and 
iodoazides according to Scheme 7.48 
7Rl H,R2 OAc 
31 Rl OAe, R2 =H 
32 Rl =H, R2 OAc (58 %) 
33Rl =OAe, R2 H(62 %) 
Scheme 7 
+ 
vi. Nucleophilic su bstitution at C-2 of pyranoside derivatives 
R2 ~Rl OA~ AcO . 
I 
34RI =H, R2 =OAe (35 %) 
35 Rl =OAe, R2=H (16 %) 
An azide is a linear triatomic anion, and because of its linear structure, is able to insert 
itself into almost any electrophilic site. The nucleophilicity of azides has been exploited 
in the synthesis of azido sugars and it has been reported that 2-0-triflates of 
carbohydrates undergo SN2 substitution reaction with azides as outlined in Scheme 8.49,50 
The advantage of this method is that stereocontrol in introduction of the azide can be 
achieved: if a manna azide is needed, a gluco substrate is used and vice versa. 
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Ph~O 
O-~~ 
Ph~O 
O--~ ..... 
BzO -.... __ .----- BzO -.... __ ----
OMe 
36 37 
(i) Sodium azide, DMF, 80°C, 2 h, 86 %. 
Scheme 8 
From the above mentioned methods for azide introduction, only two approaches were 
investigated in this project for the synthesis of the axially oriented 2-azido 2-deoxy sugar 
8. The choice was based on balancing considerations such as the practicality of the 
approach, availability of starting materials and compatibility in the required protecting 
groups. The first method investigated was the classical method of Lemieux's 
azidonitration of glycal followed by acetylation of the nitrate and subsequent de-O-
acetylation. 
2.2.1 Azidonitration of 3,4,6-Tri-O-acetyl-n-glucal 
Following the method of Lemieux41 , tri-O-acetyl glucal 7 was treated successively with 
sodium azide and CAN, giving an 84 % yield of a mixture of azido nitrates 38, 39, and 
40. Infrared bands at 2119 and 1670 cm- l of the product confirmed the presence of an 
azide and a nitrate, respectively. The lH NMR spectrum showed three anomeric peaks at 
o 5.592, 6.191, and 6.308 in a ratio of 1 '1 that correspond to three of the possible 
stereo isomers. On the basis of the coupling constants (J value) and the fact that axial-
axial couplings (Ja-a) are greater than axial-equatorial couplings (Ja-e), which are in turn 
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greater than equatorial-equatorial couplings (.fe-e), the signals were assigned to 3,4,6-tri-
O-acetyl-2-azido-2-deoxY-~-D-glucopyranosyl nitrate 40, 3,4,6-tri-O-acetyl-2-azido-2-
deoxy-a-D-mannopyranosyl nitrate 38, and 3,4,6-tri-O-acetyl-2-azido-2-deoxy-a-D-
glucopyranosyl nitrate 39, respectively. The value (8.8 Hz) of the ~-glucose is the 
largest due to the a-a coupling between HJ-H2 and that of the a-mannose (2.0 Hz) the 
smallest because of the e-e coupling between The presence in the l3C spectrum of 
three signals for anomeric carbons at 0 96.30, 97.t2 and 97.72, and nine for carbonyl 
carbons in the range 169 - 171 ppm confirmed that the product is a mixture of the above 
mentioned three isomers. 
AcO 
ACO~O 
AcO 
---
A~CO R4 
_0 
AcO 1 
AcO R 
R3 '2 
A~CO R4 1_0 
AcO I 
AcO R 
R3 '2 
7 
38,39,40 
41,42,43 
R R 
1 2 3 4 38R =H,R =ONO;z,R =H,R =N3 41Rl=H,R2=OH,RJ H,R4=N, 
42 Rl =H, R2 =OH, R' =N3, R4 H 
43 Rl = OH , R2 ~ H , R3 = N" R4 = H 
: 2 3 4 39R =H,R =ONOz,R =N"R =H 
I 2 3 4 40 R = ONO;z ,R = H, R = N3, R = H 
A~CO R,,4 
_0 
AcO I 
AcO R 
R3 I 
R2 
44 Ri H, R2 = OAe, R' =H, R4 =N3 
45Ri=OAe,R2=H ,R3=H,R4=N3 
46Ri=H,R2=OAc,R'=N3,R4 H 
47 R! =OAc,R2=H ,R' =N3, R4 H 
(i) NaN3, CAN, CH3CN, -20 DC, 84 %; (Ii) PhSH, Hunig's base, CH3CN, RT, 98 %; 
(iii) AC20, Et3N, DMAP, CH2Ch, RT, 100 %; (iv) CH3COONa, AcOH, 100 DC, 
95%. 
Scheme 9 
Though the mechanism of the azidonitration is not still clear, some studies done by 
Trahanovsky et a1. 51 ,52 led to a reasonable hypothesis for the mechanism. On studying 
oxidation of organic compounds with cerium(IV) to form a-azido-~-nitratoalkanes from 
olefins, sodium azide, and CAN, they found out that the regioselectivity of the reaction 
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was consistent with the initial addition of the azide. If that is the case, the reaction 
presumably involves addition of an azide radical to fonn a radical intennediate 
containing the azide group. The azide radical can be generated according to the reaction 
shown in equation (1). 
------------------ Eq. 1 
2N3' --..... 3N2 ----------------- Eq. 2 
The azide radical is trapped by the olefins in preference to forming nitrogen gas CEq. 2). 
The overall reaction then proceeds as shown in Scheme 10 where the resulting anomeric 
radical 2-azido-2-deoxypyranosyl 48 is oxidised by cerium(IV) to form the oxocarbenium 
ion 49 which can then react with the nucleophilic nitrate ion on either the u- or 13- face 
depending probably on the orientation of the C-2 azide and the anomeric effect. 
Alternatively, the 2-azido-2-deoxypyranosyl radical 48 may also react directly with the 
ON02Ce +4 to give 3,4,6-tri-O-acetyl-2-azido-2-deoxypyranosyl nitrate 51; or the radical 
intennediate 48 and the nitrate may fonn a 3,4,6-tri-O-acetyl-2-azido-2-deoxypyranosyl 
nitrate complex 50, which is then oxidized by cerium (IV) to yield 3,4,6-tri-O-acetyl-2-
azido-2-deoxypyranosyl nitrate 51. All of the possible routes lead, anyway, to the same 
regioselectivity. Un
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7 
ACO~ 
AcO 
AcO . 
N3 
49 
A£~ 0 Ce4+ AcO 
AcO "z.,' ... C 3+ 
- e 
N3 
48 
ACO~ 
AcO 
AcO 
N3 ON02 
50 
Scheme 10 
- 24-
A'~ 
AcO 
AcO 
N3 + 
-ON02 
49 
ACO~ 
AcO 
AcO 
N3 ON02 
51 
Ce4+ 
Regarding the stereoselectivity of the reaction, Seeberger et al.,53 noted that it is greatly 
dependent on the configuration at C-4 and the protecting groups present. They found that 
in the case of D-galactal, the steric hindrance due to the axially oriented C-4 group 
resulted in good selectivity for equatorial addition of the azide radical. However, in the 
case of D-glucal with an equatorial C-4 group, varying selectivity was obtained. In such 
cases the selectivity was dependent upon the reaction temperature, ratio of reactants, and 
the protecting groups present. 
Seeberger et al. found the 2-azido-2-deoxY-D-glucose in 8: 1 excess over the D-mannose 
derivative when they carried out the azidonitration of the tri-O-acetyl D-glucal 7 at -15°C 
to RT. 53 In contrast, we found a 1:1 ratio of the products by following a similar procedure 
to Seeberger's one but maintaining the temperature of the reaction at -20°C throughout 
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the course of the reaction. This demonstrated that selectivity of the reaction is 
temperature dependent. The 1: 1 selectivity at higher temperature could be attributed to 
the fact that neither face of the tri-O-acetyl D-glucal is particularly hindered in accordance 
with the molecular modeling results obtained by Seeberger et al..53 
In our case, the reason why a ~-mannose was not formed could be attributed to the fact 
that the axial azide may have induced steric hindrance to the attacking nitrate ion or 
nitrate complex Scheme 10) or could be due to anomeric effect. However, in the 
case where the azide is oriented equatorially, the incoming nitrate moiety doesn't 
experience any steric constraint and can hence, attack equally on both faces of the sugar 
intermediate at the same rate resulting in a 1: 1 ratio of a and ~ glucoses. 
Separation of the isomers using column chromatography was impossible at this stage as 
the products had almost the same Rf . However, it is known that the anomeric nitrate 
group can be converted into other functionalities such as hydroxyI54,55, acetyl41, and 
halides41 . In this case, it was converted into a hydroxyl group by treatment with 
thiophenol and triethylamine in acetonitrile to give 3,4,6-tri-O-acetyl-2-azido-2-
deoxymannopyranoses 41, 42, and 43 (95 % yield), in the hope that these isomers were 
separable. Absence of a nitrate peak at around 1670 cm-1 and appearance of a broader-
OH absorption in the 3300 - 3600 cm-1 region in the IR spectrum of the compound 
confirmed hydrolysis of the nitrate in the 2-azido-2-deoxY-D-manno and -D-gluconitrates 
38, 39, and 40. The upfield shift of the anomeric signals in the lH NMR also proved 
hydrolysis of the nitrate. Though a change in Rf values was observed, the differences 
were not enough for easy resolution of the isomeric mixture by column chromatography. 
However, further acetylation of the anomeric hydroxyl groups yielded separable 
acetylated products consisting of mixtures of a and ~ anomers of tetra-O-acetylated-2-
azidomannose and 2-azidoglucose, respectively. As the nitrate group can be also 
converted into an acetyl function group, the products from the azidonitration were 
alternatively acetylated using acetic acid and sodium acetate at 100°C to yield 
chromatographically separable products, 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-a-D-
mannopyranose 44, 1 ,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-p-D-mannopyranose 45, 
1 ,3,4,6-tetra-O-acetyl-2-azido-2-deoxy-a-D-glucopyranose 46, and 1,3,4,6-tetra-O-acetyl-
2-azido-2-deoxy-p-D-glucopyranose 47 in overall yield of 98 %. The desired 2-azido-2-
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deoxymannoses 44 and 45 had physical and spectroscopic properties consistent with the 
literature value.46 The presence of four acetyl peaks at ca 0 2.1 in the IH NMR spectrum 
and four carbonyl peaks at ca 0 170.0 in the I3C NMR spectrum confirmed the presence 
of four acetyl groups in each of the peracetylated 2-azido-2-deoxymannoses 44 and 45. 
As summarised in Table 1, the anomeric doublet with the J1,2 2.0 Hz and doublet of 
doublets at ca 0 5A with the = 3.7 Hz and J3,4 9.8 Hz for H-3 confirmed that the 
azide is axially oriented. Since the coupling between H-l and H-2 in the peracetylated 2-
azido~2-deoxymannose 44 is e-e, the J1,2 value was found to be in the expected range, I -
2 Hz. H-3 is coupled to H-4 and H-2, with a large a-a coupling between H-3 and H-4 and 
further coupling with H-2, resulting in a doublet of doublets for H-3. In the case of 
peracetylated 2-azido-2-deoxyglucoses 46 and 47, the J1,2 values were greater than that of 
the corresponding mannoses 44 and 45 and the signal for H~3 was an overlapping doublet 
of doublets due to almost identical a-a coupling with both H-2 and H-4 as shown in 
Table 1. 
Table 1: Comparison of the mUltiplicity and J value of selected signals of peracetylated 
2-azido-2-deoxypyranoses 44, 45, 46, and 47. 
Compouud Protou · Multiplicity I J value, Hz I 
H-la d 2.0 
Mannoses 44 and 45 H-l~ I d IA I 
i 
I 
H-3 dd 3.7 and 9.8 
i H-la d 3.7 
Glucoses 46 and 47 i H-l~ d 8.6 
i H-3 dd 9A and lOA 
In order to obtain 2-azido-2-deoxymannopyranose 8, peracetylated mannoses 44 and 45 
were treated with a catalytic amount of sodium methoxide in methanol56 (Scheme 11) 
and after 20 minutes a polar product was formed as judged by TLC. After purification 
through silica gel column chromatography, the 2~azido mannose 8 was obtained as an oil 
in 90 % yield. The spectroscopic data were consistent with the structure of the compound. 
IH and I3C NMR spectra showed absence of any acetyl signals. The anomeric proton 
signals appeared at 05.204 and 4.972 in the IH NMR spectrum, and the integration of the 
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lH NMR signals was consistent with the number of protons in the compound. The l3e 
NMR spectrum showed exactly twelve signals that correspond to the carbons in the 
mixture of isomers that constitute azido mannose 8. The mechanism for the de-O-
acetylation is shown in Scheme 12. 
44,45 
8 
(i) NaOMe, MeOH, RT, 90 % 
Scheme 11 
R-OH 
Scheme 12 
In our experience, for a small-scale (less than 1.00 gm of glucal) synthesis of the desired 
product, the protocol followed provided a reasonable yield (ca 50 %). However, on 
scaling up, significant practical difficulties were encountered. The reagents stick together 
at the bottom of the reaction flask, and effective stirring becomes difficult. Also, 
maintaining the temperature of the reaction at -20 °e for 3 h was difficult with available 
apparatus and in addition, a big column and a large volume of mobile solvents are needed 
to obtain a reasonable yield. Therefore, there was a need for us to look for a better 
method of obtaining the target key intermediate in order to proceed to the next stage of 
the project. 
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2.2.2 Azide SN2-DispIacement of 2-0-Triflate 
The second method investigated for obtaining 2-azido mannose derivatives was the SN2 
displacement of a 2-0-triflyl glucoside. This involves selective triflation of a 2- hydroxyl 
group of methyl a.-D-glucopyranoside. The strategy followed here was similar to that 
described by Oscarson et al. during the synthesis of an artificial antigen that corresponds 
to a disaccharide repeating unit of the capsular polysaccharide of Haemophilus injluenzae 
type d. 49 
The first step was to protect the 6- and 4-hydroxyls of methyl a.-D-glucopyranoside using 
Evans' method57 followed by selective protection of the 3-0 position leaving the 2-0 
hydroxyl for triflation.49,58 
\ _~O HO/\-~\~-~\. 
HO~ 
OH 
OMe 
52 
iii 
iv 
Ri = OTf, R2 H, R3 Ac 
Ri H,R2 =N3,R
3 Ac 
_44:45Ri 
vi 
(i) benzaldehyde dimethylacetal, pTsOH, DMF, 70 DC, 80 %; (ii) a. NaH, THF, RT; b. 
CuCh; c. AC20, 0 DC~RT, 80 %; (iii) Tf20, CH2Ch-pyridine, ODC; (tv) NaN3, DMF, 
70 DC, 86 %; (v) AC20, AcOH-H2S04 (I :41 v/v), RI, 90 %; (vi) NaOMe, MeOH, RT, 
90 %. 
Scheme 13 
Methyl a.-D-glucopyranoside 52 was treated with a molar equivalent of 0.,0.-
dimethoxytoluene (benzaldehyde dimethyl acetal) in i\1)N-dimethylformamide containing 
catalytic amount of p-toluenesulfonic acid monohydrate57 to afford the methyl 4,6-0-
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benzylidene-a-D-glucoside 53 in 80% yield. The presence of aromatic signals in the range 
8 = 7.504 7.354 and a characteristic singlet of the benzylidene (acetal) proton at 85.526 
in the IH Nl\1R spectrum indicated formation of a benzylidene ring in the methyl 
glucoside 53. In order to fully characterize the compound; it was peracetylated using 
acetic anhydride, triethylamine and DMAP to give acetylated glucoside 56 in 95 %. The 
physical data of the product were consistent with those reported by Evans.57 
Ph\O 
o -~~ 
HO ____ \~~_.. 
53 56 
(i) Acetic anhydride, EhN, DMAP, CH2Ch, RT, 95 %. 
Scheme 14 
Regioselective blocking of the 3-0- hydroxyl of the methyl glucoside 53 was achieved by 
the method developed by Eby et al..58 A solution of methyl glucoside 53 in THF was 
treated with sodium hydride and when evolution of hydrogen gas ceased, copper (II) 
chloride was added followed by acetic anhydride to yield the 3-0-acetylated ester 9 
(80%). The compound was identified from its IH NMR data. The presence of a singlet 
integrating for three protons at 8 2.116 indicated a monoacylated product. The position of 
the single acetate can be established on the basis ofthe type and peak frequencies of H-2 
and (potential positions of the acetyl). In most cases, protons H-3, and H-4 of 
acetoxylated carbon atoms C-2, and C-4 appear in the range of 8 3.8 - 5.7. Also, as 
mentioned earlier, a-a coupling gives larger coupling constant (9-10 Hz) compared to a-e 
(2.2-3,5 Hz) and e-e (1-2 Hz). An overlapping doublet of doublets (due to almost equal 
ara] and a;-a4 J value) signal at 8 5.321 having a coupling constant of 9.8 Hz confirmed 
that the 3-0H was the one acetylated. If the 2-0H had been acetylated, then instead of the 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
- 30-
overlapping doublet of doublets, a sharp doublet of doublets (dd) for H-2 would have 
appeared in the region due to unequivalent a2-a3 and are1 coupling constants, and H-3 
would have probably appeared further upfield than its present position. Comparison of 
the lH-NMR spectra of glucosides 56 and 9 confirms the structure of methyl glucoside 9 
explicitly. The doublet of doublets corresponding to H-2 at 8 4.908 in the lH NMR 
spectrum of peracetylated 56 is absent in the lH NMR spectrum of methyl glucoside 9, 
which confirms that the 2-0H in methyl glucoside 9 is not acetylated. 
The regioselectivity was achieved owing to the difference in the acidity of the two 
hydroxy Is. The sodium hydride abstracts the protons of the hydroxyl groups to form 
sodium alkoxides. The resulting dianion chelates with copper (II) to form a green copper 
complex (the color confirms the formation of the copper complex). Since the 2-hydroxyl 
is stronger acid than the 3-hydroxyl, the 2-alkoxide forms a stronger bond with the copper 
than that of the 3-alkoxide. Hence, 0-2 becomes less nucleophilic than the 0-3 and as a 
result the 0-3 anion reacts faster than the 0-2 to give methyl glucoside 9.58 
Methyl glucoside 9 was transformed to the 2-0-triflate after treatment of a solution of the 
compound in a I: 1 mixture of dichloromethane-pyridine with trifluoromethanesulfonic 
anhydride. A solution of the crude product in DMF was then treated with sodium azide at 
70°C to afford the 2-azido-2-deoxymannoside 55 in 86 % yield (from methyl glucoside 
9).49 The fJ..-D-manno configuration of the compound was assigned by NMR data. The 
singlets at 8 3.404 and 130 correspond to the OMe and OAc of the compound, 
respectively. The benzylidene singlet appears at 0 5.571. The anomeric signal at 0 4.696 
has a J],2 value of 1.5 Hz, which is less than that of methyl glucoside 9 (Jl,2 = 4.0 Hz) 
confirming that the orientation of H-2 in 2-azido-2-deoxymannoside 55 is equatorial (in 
other words the 2-azide is axial) as J of e-e < a-e. The signal for H-3, which appeared, as 
an overlapping doublet of doublets in methyl glucoside 9, is now a resolved doublet of 
doublets at 85.432 implying that the configuration at C-2 has changed and the 2-azide is 
axial. 
2-Azido-2-deoxymannoside 55 was then subjected to acetolysis59 in acetic anhydride and 
acetic acid - sulfuric acid (41: I v/v) solution and after purification afforded the 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
- 31-
peracetylated 2-azido-2-deoxymannoses 44 and 45 in 87 % overall yield. The physical 
andNMR data were in agreement with the literature values and with the same 
compounds synthesised as described earlier (Scheme 9). 2-Azido mannose 8 was 
obtained by de-O-acetylation of peracetylated 2-azido-2-deoxymannoses 44 and 45 as 
before (Scheme 11). 
After obtaining the 2-azido mannose 8, with the required regio and stereo orientations, 
the next challenge was the selective protection and deprotection at 0-6 and 0-1 of the 
mannose while keeping 0-3 and 0-4 protected (Scheme 15). 
HX:±\N~O 
HO 
HO 
8 
OR 
57 58 j 
60 59 
Scheme 15 
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2.3 SYNTHESIS OF SELECTIVELY PROTECTED 2-AZIDO MANNOSE 5 
By inspection of structure of 2-azido mannose 8, differences in the reactivity of the 
hydroxyls can be expected. The primary C-6 and the anomeric hydroxyls can be expected 
to have different reactivities from each other and the rest of hydroxy Is. 
2.3.1 Tritylation 
As shown below in Scheme 16, during the course of our study towards the synthesis of 
compound 5 (Scheme 1), an attempt was made to synthesise a 6-0-trityl mannose from 
2-azido mannose 8. 
Tr~l~o HO . 
HO 
OH OH 
8 61 
Scheme 16 
Tr~N3, -_l> _0 
AcO 
AcO 
[
62R=AC 
63R=H 
OR 
The trityl group is widely used as a blocking group in synthesis for primary hydroxyls of 
carbohydrates. The classical method for the tritylation of carbohydrates is carried out in 
absolute pyridine and involves reaction of the substrate containing hydroxyls with a trity! 
chloride at a temperature ranging from room temperature to 100 °C.60 The reaction 
proceeds by initial formation of a N-tritylpyridinium salt from the reaction between tdty! 
chloride and the solvent (pyridine). The salt then gives the corresponding tritylated 
compound and pyridinium chloride on treatment with the substrate alcohol.61 
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Scheme 17 
The importance of the trityl group in carbohydrate chemistry is attributed due to:62 
i. the excellent regio-selectivity of the trityl cation towards primary hydroxyls 
ii. cleavage of trityl ether under mild reaction conditions and; 
iii. the advantage that many carbohydrates are soluble in pyridine. 
The bulkiness of the trityl group enhances the affinity of the reagent towards the 
sterically less hindered hydroxyl. But very rare exceptions are reported in which a 
secondary hydroxyl is tritylated and a more frequent instance where there is an 
interaction between an anomeric hydroxyl with the tritylating agent.62 However, under 
standard reaction conditions tritylation of hydroxyls other than the primary ones is 
relatively very slow6o and as a result monotritylation can be achieved by using one 
equivalent of the reagent.62 
Trityl ethers may be cleaved under acidic conditions or by hydrogenation depending on 
the substrates. Among the most common protocols are: 
i. boiling ofthe ether with 80 % acetic acid,62 
ii. treatment ofthe ether with 1 M of aq. HCI in dioxane,63 
iv. treatment of the ether with sodium in ammonia,64 and 
v. catalytic hydrogenolysis of the ether.62 
Although the tritylation and deprotection of trityl ether seem to be simple, treatment of a 
solution of 2-azido mannose 8 in pyridine with trityl chloride did not produce a product 
as judged by TLC even after stirring at RT for a week. Acetylation of the reaction 
mixture resulted in peracetylated 2-azido-2-deoxymannoses 44 and 45 implying that the 
tritylation process did not take place at all. 
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Chaudbary et al. reported61 a high yield of mono-tritylated a-methylglucoside usmg 
DMAP, triethylamine, and DMF instead of pyridine as a base and solvent, respectively. 
We accordingly attempted to introduce a trityl group into 2-azido mannose 8 using this 
method, but the reaction was unsuccessful. Though we did not conduct detailed studies as 
to why the reactions failed to give desired products, the failure of the reaction could 
probably be that since an azide ion is a linear tri-atomic species and hence the axially 
oriented rod-like azide might have caused steric hindrance for the incoming trityl cation; 
2.3.2 Deprotection of Anomeric Oxygen 
With the failure of the tritylation route, we looked for another route that employs readily 
available starting materials and gives a high yield of the required compounds. The route 
shown in Scheme 18 seemed feasible. 
\ 0 HO~~v\ i 
HO-~ --,.. 
OHI 
OMe 
52 
v 
BnO___ N3 
RO/.\~~±O. 
AcO~~ I 
OMe 
-64 R=H 
vii ~5 R=Ac 
(0 benzaldehyde dimethylacetal, pTsOH, DMF, 70°C, 80 %; (ii) a. NaH, THF, 
RT; b. CuCb; c. Ac20, 0 °C-+RT, 80 %; (iii) Tf20, CH2Cb-pyridine, O°C; 
(iv) NaN3, DMF, 70°C, 80 %; (v) NaCNBH3, HCl in ether, THF, RT, 75 %; 
(vi) Ac20, DMAP, Et3N, CH2Cb, RT, 85 %. 
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65 AcO 
OH 
66 
Scheme 18 
2-Azido-2-deoxymannoside 55 was obtained as explained in Scheme 13. When the 2-
azido-2-deoxymannoside 55 was treated with sodium cyanoborohydride and hydrogen 
chloride in THF, the benzylidene ring was opened regioselectively towards the C-6 to 
give methyl 3-0-acetyl-2-azido-6-0-benzyl-2-deoxymannopyranoside 64 in 75 % yield.65 
The structure of the compound was confirmed by IH and 13C NMR spectroscopy. The 
absence of a singlet due to the benzylidene proton peak at (5 5.571 and appearance of an 
AB-quartet for benzylic protons at (5 4.602, as well as a broad singlet at (5 2.814 for OH 
confirmed the opening of the benzylidene ring in the 2-azido-2-deoxymannoside 55. 
After D20 wash the IH NMR spectrum showed that the OH is attached to C-4. In 
addition, the appearance of the C-6 peak at ca 0 68.0 in the l3C NMR spectrum of the 
compound confirmed that the 6-0H is still protected. The singlet peaks at 0 2.149 and 
3.375 of the IH NMR; and characteristic carbonyl at 0 171.04 and methoxy peaks at 0 
55.30 in the l3C NMR spectra corresponding to acetyl and methyl groups, respectively, 
confirmed the 6-0-benzylated mannoside 64. Acylation of 6-0-benzylated mannoside 64 
with acetic anhydride, DMAP, and triethylamine in dichloromethane yielded 3,4-di-O-
acetyl-2-azido-6-0-benzyl-2-deoxymannopyranoside 65 in 80 % yield. Two singlet 
acetoxy methyl peaks at ca 0 2.1 in the NMR and also two carbonyl peaks at ca 0 
170.0 in the l3C NMR confirmed presence of two acetoxy groups in the compound. 
Different attempts were made to selectively cleave the methyl mannoside 65. Jansson et 
al. synthesized 2,3,4,6-tetra-O-benzyl-~/a-D-glucopyranose from the corresponding 
methyl a-D-glucopyranose derivative.66 Following their procedure, a solution of methyl 
mannoside 65 in acetic acid was treated with trifluoromethanesulfonic acid at 80°C. 
After 1 h TLC showed the presence of two products, neither of which was the desired 
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methyl 3,4-di-O-acetyl-2-azido-6-0-benzyl-2-deoxymannopyranoside 66 (Scheme 19). 
The less-polar product was identified as methyl 3,4-di-O-acetyl-2-azido-2-
deoxymannopyranoside 67 where the benzyl had been removed and the more-polar had 
retained the methyl group but lost the other protecting groups (the benzyl and acetyls) i.e 
methyI2-azido-2-deoxymannopyranoside 69. 
Bn~o N3 
1
-0 
AcO 
AcO-
65 
i 
OMe OMe 
.. [67R=H 
II 
68 R= Ac 
+ 
R~O N~O 
RO 
RO 
OMe 
[
69R H 
ii 
68 R= Ac 
(i) AcOH, trifluoromethanesulfonic acid, 80°C; (ii) Ac20, pyridine, RT. 
Scheme 19 
The structures were deduced from I H NMR spectra. The 1 H NMR spectrum of 
methylmannoside 67 showed neither the aromatic nor the benzyl protons' characteristic 
signals although two singlet acetoxy methyls and a methoxy signals were identified at ca 
is 2.1 and 3.4, respectively. In contrast, in methyl 2-azido-2-deoxymannopyranoside 69, 
only a methoxy signal appeared at ca is 3.4 of the lH NMR spectrum. Both methyl 
mannosides 67 and 69 gave peracetylated methyl mannoside 68 on acetylation with the 
structure of peracetylated methyl mannoside 68 again assigned by IH NMR 
When selective deprotection of the O-methyl failed, attempts were made to convert the 
O-methyl in methyl mannoside 65 to a phenylsulfanyl by treating it with PhSSiMe3 and 
BF3.EhO in dichloromethane at room temperature.67 However, the reaction was not 
successful at all as starting material was recovered from the reaction mixture, and a 
stronger Lewis acid may be required to for this reaction. 
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Though the described route did not provide us with the desired intermediate 66, it helped 
us to obtain 2-azido mannose 8 in a better yield than the route via azidonitration. In order 
to obtain the desired 3,4-di-O-acetyl-2-azido-2-deoxymannose (5), we therefore decided 
to look at alternative routes which did not utilize a methyl glycoside and incorporated a 
selectively removable anomeric substituent. 
2.3.3 Benzylidene Acetals 
The third methodological principle that we tried was to selectively protect the 6-0H with 
the p-methoxybenzyl group. It has been reported that this protecting group can be 
selectively introduced and cleaved in the presence of other protecting groups. It could 
undergo oxidative cleavage under neutral conditions using 2,3-dichloro-5,6-
dicyanobenzoquinone in dichloromethane-water mixtures to give a free hydroxyl and p-
methoxybenzaldehyde.68 Acetyl, benzyl, benzoyl, BOM, isopropylidene acetals, MEM, 
MOM, TBS, THP, and tosyl protecting groups, and functional groups like epoxide, 
alkenes, and ketones are found to be tolerant to the reaction conditions.69 Later, selective 
cleavage of this group can be optimized by using CAN in acetonitrile-water (9: 1) 
mixtures to afford the desired alcohol without affecting acetyl, benzyl, and azide 
groups.70)I,n,73 p-Methoxybenzyl has also been used as an in situ-removable protecting 
group in the simple one-pot synthesis of globotetraose tetrasaccharide using N-
iodosuccinimide-trifluromethanesulfonic acid.74 
The p-methoxybenzyl is introduced by etherification using p-methoxybenzyl chloride and 
sodium hydride in DMF or DMSO. But when selective protection is required in diols, 
regioselective reductive ring opening of p-methoxybenzylidene acetals results in 
p-methoxybenzyl ethers and a free hydroxyl. 
Benzylidene acetals are frequently used in protection of diols. They show stability to 
most bases, mild oxidants, and metal hydrides, but they are readily cleaved by N-
bromosuccinimide, ozone, and strong bases like alkyllithium reagents?5,76 They also can 
be cleaved by hydrogenolysis in the presence of metal catalyst such as Pd and Pt, and 
acid hydrolysis. Another great virtue of benzylidene acetals is that they can undergo 
Un
ive
rsi
ty 
of 
C
pe
 To
wn
- 38-
regioselective reductive ring opening to give a free OH and benzyl ethers. Because of 
their versatility, the reductive cleavage of benzylidene acetals of carbohydrates is well 
documented (Scheme 20). 
Liptak and coworkers reported regioselective reductive cleavage of a benzylidene acetal 
using LiAlH4-AlCb to afford a free hydroxyl group at the less hindered position and the 
benzyl ether of the more hindered hydroxyL77 Garegg et al demonstrated that the benzyl 
ether of the less hindered hydroxyl and a free hydroxyl group at the more hindered 
position can be obtained with NaCNBH], and diethyl ether saturated with HCl in THF in 
good yield.78 
Ph 
OBn 
BnO 
70 
ii 
72 
(i) AlCh/LiAlH4; (ii) NaCNBH3, HCl, THF, 93 %. 
Scheme 20 
BnO OH BnO~OBn 
BnO 
71 
HO OBn Bno~ 
BnO I 
OMe 
73 
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The same authors have also reported that in using BH3.NMe3 as reducing agent and AlCh 
as the acid, the regioselectivity in the cleavage of the benzylidene acetal depends on the 
choice of the solvent though no explanation is given for this observation.78 Using toluene 
as solvent, the benzyl group in the product positioned at 0-4 and the 6-0H is free. With 
THF as solvent, the opposite result is obtained (Scheme 21). 
74 
76 
Scheme 21 
p-Methoxybenzylidene acetals, which have an electron donating group at the p-position, 
hydrolyse 10 times faster than the corresponding benzylidene acetals.79 Deprotection of 
these protecting groups can be achieved using 80 % acetic acid or DDQ; however, a mild 
cleavage condition with Selectfluo?M 77 in CH3CN or CH3N02 having 5 % water 
content has been reported recently.80 They also undergo similar kind of regioselective 
reductive ring opening of benzylidene acetals depending on reaction conditions, solvent, 
and electrophile used. Combination of reagents such as LiAIH4-AlCb,81 BH3.NMer 
AICh,82 BH3 in THF at high temperature,83 or NaCNBH3-TMSCI in MeCN70 results in 
the p-methoxybenzyi ether of the more hindered hydroxyl and a free hydroxyl at the less 
hindered position (Scheme 22). 
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Scheme 22 
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ii • H~~O, ~O~ 
OMe 
80 
Nevertheless, by using NaCNBH3 in a mixture of CF3C02H and DMF the opposite result 
can be obtained, where the PMB ether is positioned at the less hindered 6-hydroxy1.7o 
PI'vIP\~ ____ 0 __ :aM~BO 0 ii 
~no~ BnO -
BnO I BnO 
OMe OMe 
78 81 
Scheme 23 
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Benzylidene acetals are normally prepared by two methods: 
(i) Direct condensation of a carbonyl derivative 
This method involves the reaction of a diol with benzaldehyde or 
p-methoxybenzaldehyde in the presence of a protic acid or Lewis acid (usually zinc 
chloride is used).84,85,86 One mole of water is formed as a by-product and has to be 
removed to avoid hydrolysis of the acetals. The reaction proceeds according to the 
following scheme. 
Co~ ,,~. )H + ~ c=o + H OH / H I / CO-C-OH ~H \ 
... 
-r H 
Scheme 24 
(ii) Transacetalation 
This method is based on acetal exchange in the presence of catalytic amount of an acid. 
The reaction takes place using p-methoxybenzaldehyde dimethyl acetal or benzaldehyde 
dimethyl acetal in the presence of p-toluenesulfonic acid in DMF to prepare their 
respective benzylidenes as shown in Scheme 25.57 The reaction can be carried out at high 
temperatures and reduced pressure in order to remove the two moles of methanol 
produced as by-product during the course of the reaction. 
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The second method is more advantageous than the first method. In this transacetalation, 
strictly anhydrous reaction conditions can be followed whereas in the first continuous 
removal of water is required. 
2.3.3.1 p-Methoxy benzyl ether 
By virtue of its easy introduction, removal and compatibility with the protecting groups 
that are in our intermediate compounds, selective protection of the 6-0H with p-
methoxybenzyl was taken as an option. Accordingly, a solution of 2-azido-2-
deoxymannopyranose 8 and catalytic amount of p-toluenesulfonic acid in DMF was 
treated with p-methoxybenzaldehyde dimethyl acetal at 70°C to afford 2-azido-4,6-(4-
methoxybenzylidene)-2-deoxymannopyranose 82 in 75% yield. The compound and ring 
size of the compound were ascertained by IH NMR data. The doublets at ca 8 7.8 and 6.8 
correspond to the two sets of protons on the aromatic ring of the p-methoxybenzylidene 
acetaL The acetal proton appeared at ca 8 5.5 confirming that the acetal is a six 
membered ring (dioxane ring), as does the acetal carbon at ca 8 102.1 in the I3C NMR of 
the compound.87 methoxy carbon gave a signal at ca 8 3.8. The reaction was carried 
out under reduced pressure in order to remove the MeOH produced (see Scheme 25) so 
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that hydrolysis of the product wouldn't take place. The transacetalation takes place 
according to the mechanism outlined above (Scheme 25). 
p-Methoxybenzylidene mannose 82 was taken up in dichloromethane for acetylation 
using acetic anhydride, catalytic amount of DMAP, and triethylamine to give 1,3-di-O-
acetyl-2-azido-4,6-0-(p-methoxybenzylidene)-2-deoxymannopyranose 83 in 80 % 
yield. In the NMR spectrum of the compound, the characteristic proton signals of the 
aromatic ring appeared at ca (3 7.2 and 6.9. The acetal and methoxy proton signals 
showed up at ca (3 5.5 and 3.8, respectively. The presence of two acetyl groups in the 
compound was confirmed by the presence of two singlet acetoxy methyl signals at ca (3 
2.1 in the IH NMR spectrum and two carbonyl signals ca (3 160 in the 13C NMR spectrum 
of the compound. 1,3-Di-O-acetyl-2-azido-2-deoxy-6-0-(p-methoxybenzyl)mannopyra-
nose 84 was obtained in 70 % yield by treating a solution of peracetylated p-
methoxybenzylidene mannose 83 in DMF with NaCNBH3 and CF3C02H.70 Absence of 
an acetal proton signal at around (3 5.5, appearance of a AB-quartet at (3 4.513 and a broad 
singlet peak at ca (3 2.7 of an OH proved the opening of the acetal and formation of a p-
methoxybenzyl ether in which the methoxy showed up at (33.802. D20-washed IH NMR 
spectrum showed that the OH is attached to C-4 and this was also supported by the 
appearance of C-6 signal at ca (3 68.1 in the BC NMR because protected C-6 of an ether 
appears at ca. (3 68.0. 
The regioselectivity of this reaction could be mainly due to steric factors. Since the acetyl 
at 0-3 is not bulky enough to exert steric hindrance to an incoming electrophile and also 
the I-t is too small to experience such hindrance, protonation can either take place at 0-4 
or 0-6 depending on their relative acidity. But primary alcohols are more acidic than 
secondary ones. And hence, 0-4 is protonated in preference to 0-6 and a 
p-methoxybenzylic cation intermediate is formed, which, is then stabilized by the slightly 
basic polar solvent, D1VIF?O Then reduction with the reducing agent is followed to give 
the corresponding 6-0-(p-methoxybenzyl) ether 84 as outlined in Scheme 26. 
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Acetylation of 6-0-(p-methoxybenzyl) mannose 84 afforded 1,3,4-tri-0-acetyl~2-azido-2-
deoxy-6-0-(p-methoxybenzyl)mannopyranose 85 in 85 % yield. The downfield shift of 
H-4 to 8 5.389 in peracetylated 6-0-(p-methoxybenzyl) mannose 85 from 4.102 in 6-0-
(p-methoxybenzyl) mannose 84 (8 3.987 in the case of the ~ isomer) shows that the 0-4 
in 6-0-(p-methoxybenzyl) mannose 84 was not protected. And hence, moved downfield 
upon acetylation. Three acetoxy peaks corresponding to the three acetyls in peracetylated 
6-0-(p-methoxybenzyl) mannose 85 appeared at ca 8 2.1 in the lH NMR spectrum. 
Carbonyl signals at 8 170.01, 169.34, and 168.24 in the 13C NMR spectrum of 
peracetylated 6-0-(p-methoxybenzyl) mannose 85 indicated presence of three acetyl 
groups. The acetyl at the anomeric center was selectively removed after treatment of a 
solution of peracetylated 6-0-(p-methoxybenzyl) mannose 85 in DMF at 50°C with 1.2 
eg. of hydrazine acetate to afford 3,4-di-0-acetyl-2-azido-2-deoxy-6-0-(p-
methoxybenzyl)mannopyranose 86 in 82 % yield. 88 IH NMR showed two signals at ca 8 
2.0 indicating the presence of only two acetyls. Upfield shift of the anomeric peak from 8 
6.090 to (55.159 in the IH NMR is also an indication of anomeric de-O-acetylation. 
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PtvIB~N3 2 -0 RO 
AcO 
Iv [84 Rl =Ac, R2 =H 
85 R! =R2 =Ac 
V [86 RI = H, R2 = Ac 
OR! 
(i) p-methoxybenzaldehyde dimethylacetal, p-TsOH, DMF, 70°C, 75 %; (ii) AC20, 
DMAP, Et3N, dichloromethane, RT, 80 %; (iii) NaCNBH3, CF3C02H, DMF, RT, 
70 %; (iv) AC20, DMAP, Et3N, dichloromethane, RT, 85 %; (v) hydrazine acetate, 
DMF, 50°C, 82 %. 
Scheme 27 
Synthesis of 6-0-(p-methoxybenzyl) mannopyranose 86 was a major achievement for our 
project. The next step was to couple 6-0-(p-methoxybenzyl) mannopyranose 86 with the 
linker benzyl N-(3-hydroxypropyl)carbamate 88 to obtain carbobenzoxyamino 3,4-di-O-
acetyl-2-azido-2-deoxy-6-0-(p-methoxybenzyl)mannopyranoside 89 (Scheme 28). As 
the anomeric hydroxyl has to be transformed into a good leaving group in order for 
glycosidation to take place, 6-0-(p-methoxybenzyl) mannose 86 had to be transformed 
into an imidate. 
A solution of 6-0-(p-methoxybenzyl) mannopyranose 86 and trichloroacetonitrile in dry 
dichloromethane was treated with finely powdered K2C03 to give 3,4-di-0-acetyl-2-
azido-2-deoxy-6-0-(p-methoxybenzyl)-D-mannopyranosyl trichloroacetimidate 87 in 
65 % yield. 89 Since imidate formation is reversible, the thermodynamically more stable 
a-imidate was the major product. The structure of the compound was ascertained by 1 H 
and 13C NMR data. Downfield shift of the anomeric signal to 0 6.266 signifies 0-
alkylation of the OH. Appearance of characteristic imidate peak at 8 8.741 was also an 
indication of formation of the imidate. Besides shift of anomeric peak in the l3C NMR, 
the presence of an additional peak at 8 160.09 that corresponds to the imidate carbon is 
evidence of the existence of a trichloroacetimidate.89 The Col orientation was confirmed 
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by the 1 value ofH-1 and dd signal ofH-2 in the IH NMR of the compound. small 1 
value (1.8 Hz) of H-1 corresponds to e-e coupling. The signal corresponding to H-2 
showed up as a doublet of doublet as a result of unequal coupling between H-1 H-2 and 
H-2 H-3. Coupling ofH-2 with H-3 afforded a doublet with a 1 value of9.7 which 
was then split into doublets (1 3.6 Hz) by coupling with 1 to give an overall doublet 
of doublet signal for H-2. If the C-1 orientation had been [3, 11,2 and 12,3 would have 
closely similar values, resulting in an overlapping doublet of doublets for H-2. 
PMBO 
AcO 
AcO -...l.....",----"" 
z 
86 
87 
o 
II 
-C-O-CHzPh 
OH 
88 
(i) Trichloroacetonitrile, K2C03, CH2Ch, RT, 65 %. 
Scheme 28 
87 
°llCC13 
NH 
PMB~N3 
-0 
AcO 
AcO 
O~NHZ 
89 
However, glycosidic bond formation between imidate 87 and the carbamate 88 
employing Lewis acids such as BF3-EtzO was not successful. The position (being at the 
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primary) might have added to the susceptibility of the PMB group to the acids, which 
were removed under the reaction conditions prior to glycosidation and probably led to 
formation of an anhydro compound. 
Therefore, we had to look for another protecting group with greater stability to acids than 
the PMB. As mentioned earlier PMB groups are 10 times more labile to acids than their 
corresponding benzyl ethers. Hence, we decided to try benzyl ether as a protecting group 
for the 0-6 in the hope that this could be later selectively removed without reducing the 
azide with reagents such as BBr3. The benzyl group was introduced in the same fashion 
as the PMB was introduced. 
2.3.3.2 Benzyl ether 
A solution of 2-azido mannose 8 and p-toluenesulfonic acid monohydrate in DMF was 
treated with benzaldehyde dimethyl acetal (ct., ct. -dimethoxytoluene) at room temperature 
to afford 2-azido-4,6-0-benzylidene-2-deoxY-D-mannopyranose 90 in 75 % yield.57 The 
appearance of an acetal signal at ca 8 5.553 and ca 102 in the IH and l3C NMR of the 
product, respectively, indicated formation of the benzylidene ring. The compound was 
fully characterized after being peracetylated. The 4,6-0-benzylidene mannose 90 was 
taken up in dichloromethane and acetic anhydride, triethylamine, and DMAP were then 
added to give 1 ,3-di-0-acetyl-2-azido-4,6-0-benzylidene-2-deoxY-D-mannopyranose 91 
after stirring for 0.5 h at room temperature in an excellent yield. The acetal signals both 
in IH and 13C NMR spectra were intact ascertaining that the benzylidene ring was 
unaffected. Two singlets at 8 2.175 and 2.159 (8 184 and 2.151 in the case of the (3 
anomer) in the IH NMR spectrum, the two carbonyl signals at 8 170.31 and 168.62 (8 
170.34 and 168.42 for the (3 anomer) and two methyl signals at 8 21.10 and 20.80 (8 
20.88 and 20.81 in the case of the (3 anomer) in the 13C NMR spectrum witnessed the 
presence of two acetyl groups. H-3 appeared as a doublet of doublet at 8 5.470 whereas 
H-4 showed a signal far upfield at ca 8 4.0 indicating that 3-0 was acetylated. H-la 
appeared at 8 6.080 as a doublet with a J = 1.6 Hz. 1,3-Di-0-acetyl-2-azido-6-0-benzyl-
2-deoxY-D-mannopyranose 92 was obtained in 65 % yield after the benzylidene ring in 
peracetylated 4,6-0-benzylidene mannose 91 was regioselectively opened upon treatment 
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with sodium cyanoborohydride and ether saturated with HCl using THF as solvent. The 
product was assigned by NMR. The disappearance of the acetal peaks in both 1 Hand 13C 
NMR spectra and on the other hand appearance of CH2Ph signals confirmed opening of 
the ring. The CH2 gave a distorted quartet at (3 4.578 in the IH NMR spectrum of the 
product. Appearance of a broad singlet peak at (3 2.896 of the IH NMR of the product 
corresponding to OH was additional evidence of the opening of the benzylidene ring. 
Opening of the ring towards 0-6 was ascertained by the fact that H-4 appeared upfield ca 
(34.0 in the IH NMR and C-6 appeared at 8 69.905. D20 wash also confirmed that the 
OHhad a long range coupling with H-4 not with H-6 i.e the OH is attached to C-4. 
A solution of 6-0-benzyl mannose 92 in dichloromethane was treated with acetic 
anhydride, triethylamine, and DMAP to afford 1,3,4-tri-O-acetyl-2-azido-6-0-benzyl-2-
deoxy-D-mannopyranose 93 in 85 % yield. The number of acetyl groups present in the 
compound was consistent with IH and l3C NMR spectra. The OH peak is absent in the IH 
NMR spectrum. H-4 shifted downfield to (3 5.233 while the other protons didn't show 
significant change. The downfield shift of H-4 indicates that 0-4 is acetylated and thus 
the OH in 6-0-benzyl mannose 92 was positioned at C-4. Anomeric de-O-acetylation was 
achieved in 80 % yield to obtain 3,4-di-O-acetyl-2-azido-6-0-benzyl-2-deoxY-D-
mannopyranose 66 by treatment of peracetylated 6-0-benzyl mannose 93 with hydrazine 
acetate at 50°C in DMF. The anomeric proton (a) shifted upfield to 8 5.134 while the 
rest of the protons were intact and an additional peak of OH appeared at 8 4.247. These 
pieces of information prove that anomeric de-O-acetylation took place. A D20 shake IH 
NMR also gave sharper signals for both a and f3 anomeric protons signifying that the OH 
is attached to C-l. The number of acetyls in the compound was in agreement with the 
number of acetoxy and carbonyl peaks in the I Hand l3C NMR spectra. 
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(i) et.,et.-Dimethoxytoluene, p-TsOH, DMF, RT, 75 %; (ii) AC20, DMAP, Et3N, 
dichloromethane, RT, 90 %; (iii) NaCNBH3, HCI-ether, THF, RT, 65 %; (iv) Ac20, 
DMAP, Et3N, dichloromethane, RT, 85 %; (v) hydrazine acetate, DMF, 50°C, 80 %. 
Scheme 29 
2.4 PHOSPHORYLATION 
Satisfied with the result achieved, we wanted to attempt synthesis of the 
a-hydrophosphonate monomer 3 from 6-0-benzyl mannose 66. Synthesis of this 
monomer having the right orientation at the anomeric center was crucial for synthesis of 
the desired target 2 
Different techniques for the preparation of hydrophosphonates have been reported so far. 
Marugg et al demonstrated a general and simple method for the preparation of d-
nuc1eoside-3' -hydrophosphonates using monofunctional phosphitylating reagents 97 and 
95 according to Scheme 30.90 Phosphitylation of 94 with reagent 95 yielded intermediate 
96. Treatment of a solution of 96 in dioxane with acetic acid followed by excess pyridine-
water gave homogeneous 99 in 87 % yield. Alternatively, treatment of a solution of 94 in 
dioxane and pyridine with a slight excess of 1.25 molar solution of salicylchlorophosphite 
97 in dioxane followed by treatment of the reaction mixture with water gave them 88 % 
of hydrophosphonate 99 (Scheme 30). 
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Scheme 30 
The same authors slightly modified the second phosphitylation method when they were 
synthesizing a fragment of G 1 cNAc-a(l ~P~6)-G 1 cNAc of the cell wall polymer of 
Staphylococcus Lactis having repeating N-acetyl-D-glucosamine phosphate units. 91 They 
treated a solution of N-acetylglucosamine 100 in dioxane containing triethylamine with 
salicylchlorophosphite 97 followed by hydrolysis to obtain hydrophosphonate 102 in a 
yield of86 % (Scheme 31). 
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It has been described that none sugar hydrophosphonates can also be synthesized using 
salicyl chlorophosphite phosphitylating reagent. Brimacombe et al. synthesized a series 
of hydrophosphonates during the synthesis of further substrate analogues of early 
intermediates in the biosynthetic pathway of glycosylphosphatidylinositol membrane 
anchors.92 They showed that treatment of a solution of salicyl chlorophosphite in THF 
with a solution of the corresponding alcohol in THF-pyridine followed by hydrolysis with 
1M aq. triethylammonium hydrogen carbonate buffer solution yielded the respective 
hydrophosphonates90 (Scheme 32). 
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99% 
103 104 
0 
HOrOCI6H33 
i 
Et3HN Ilr lI> f-o OC16H33 
94% 
OCH3 H OCH3 
105 106 
0 
+ Ilr 
HOrOClSH37 
Et3HN P-O OC 1sH37 
lI> 
92% H OC1sH37 
OC1sH37 
107 108 
0 
i II + CgH170-P-O NHEt3 CgHl70H 
,.. I 
87% H 
110 
109 
(i) a. Salicylchlorophosphite in THF, pyridine-THF; b. 2.1 M (aq) triethylammonium 
hydrogen carbonate. 
Scheme 32 
The other method of preparing hydrophosphonates is usmg in situ prepared tri-
imidazolylphosphine phosphitylating reagent. The reagent is prepared from PCh, 
imidazole, and Et3N in acetonitrile. Nikolaev et al elucidated use of this reagent for the 
synthesis of hydrophosphonates 113 and 114 from the corresponding alcohols (Scheme 
33).93 
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(i) Tri-imidazolylphosphine, CH3CN, 100 %. 
Scheme 33 
The same authors further elaborated the scope of the reagent when they were synthesizing 
phosphodisaccharide synthetic probes and substrate analogues for the elongating a-D-
mannopyranosylphosphate transferase in the Leishmania (Scheme 34).94 
o 
AcO II '~/OAC . OAc OR AcO o-f-H ~~o ACO<---~~' .. I <,OAc OAc' -OEt3HN 
'! II ~" __ 0 ___ r-.,· ~7 AcO- \' O~O - ~. ", AcO,/ ~,_J../ 
OAc "OAc AcO~ \. "O~O 
OAc 'OAc 
[
115R H 
i + 
116 R = PO(H)OEt3HN 
117 
Scheme 34 
Bearing these H-phosphonating techniques in mind, we tried to adopt them to our own 
substrate 3, 4-di -O-acetyl-2-azido-6-0-benzy 1-2-deoxY-D-mannopyranose 66. 
Experiments employing triimidazolylphosphine and salicyl chlorophosphite with 
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triethylamine as a base were unsuccessful. However, reaction was moderately successful 
when a solution of 6-0-benzyl 66 in dioxane-pyridine (in 3: I ratio) was treated with 
1.25M solution of salicyl chlorophosphite in dioxane followed by quenching with TEAB 
to afford hydrophosphonate 118. The reaction failed to go to completion and only ca 50 
% conversion was achieved, with starting material being recovered after work-up. IH as 
well as 31p NMR data of hydrophosphonate 118 were in complete accordance with its 
proposed structure. The characteristic NMR data for hydrophosphonate 118 were as 
follows: a singlet 31p signal at 8 -0.816; a doublet signal at 8 6.949 with a J value of 
647.1 Hz that corresponds to the P-H in the IH NMR spectrum were typical for a,-
hydrophosphonate derivatives.93 The anomeric proton appeared at 8 5.622 as an 
unresolved doublet of doublets with .hr 8.4 Hz and J1,2 = 1.2 Hz. 
B~O 1!~0 
AcO 
AcO-
't,., 
66 
if 
OH 
B~O N3.
-0 
AcO 
AcO . 0 
I II 
O-P-H 
118 
(i) a. Salicyl chlorophosphite in dioxane, dioxane-pyridine; b. aq. TEAB, RT, 40 %; (ii) a. 
SaJicyl chlorophosphite, Et3N, dioxane; b. aq. TEAB; (iii) a. 
imidazolyl phosphine, CH3CN; b. aq. TEAB. 
Scheme 35 
An investigation was carried out on the model compounds 2,3,4,6-tetra-O-acetyl-D-
glucopyranose 119 and 3,4,6-tri-O-acetyl-2-azido-2-deoxy-D-manno and-D-
glucopyranose 121 to find out if the reaction goes to completion. Model 2,3,4,6-tetra-O-
acetyl-D-glucopyranose 119 has a participating group at C-2 while the 2-azido-2-
deoxypyranoside derivative 121 bears a non-participating group at the same position 
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(Scheme 36). The reaction took place on both models but without going to completion. 
These findings proved that the type (participating or non-participating) and orientation of 
the C-2 constituent does not play any role in preventing the reaction from going to 
completion and on the stereochemistry of the product. 
ACO\ 
~ AcO-AcO \_~ 
OAc OH 
119 
ACO~ 0 
AcO~v\ 
AcO-~ 
N3 OH 
121 
A~O 0 
AcO 
AcO~ \ 0 
OAcl II 
O-P-H 
+ 1_ 
Et3HNO 
120 
ACO~O 
AcO~~v\ 
AcO~ 0 
N3 • II 
O-P-H 
122 
(i) a. Salicyl chlorophosphite in dioxane, dioxane-pyridine, RT; b. aq. TEAB 
Scheme 36 
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3. CONCLUSION 
This study has succeeded in developing methods for the synthesis of the selectively 
protected Il-l-hydrophosphonate 118, which is the cornerstone for synthesis of potential 
glycoconjugate vaccine candidates. It has also been demonstrated that the most efficient 
route to the desired precursor 2-azido-2-deoxymannopyranose derivative 8 is via 
selective protection of methyI4,6-0-benzylidene-a-D-glucoside followed by azide 
displacement of a 2-0-triflate derivative rather than via azidonitration of protected glucal. 
The former route gave higher yields and avoided the difficult separations of 
diastereoisomers in the latter route. The impracticability of 6-0-tritylation of 2-
azidomannose 8 was also demonstrated, establishing that this was not a feasible route to 
3,4-di-O-acetyl-2-azido-2-deoxymannose derivative 5. 
In the future, mannose unit 66 will also be converted to a glucoside containing a linker 
suitable for subsequent conjugation to a protein. Selective removal of the 6-0-benzyl 
group by non-hydrogenolytic methods will allow for linking to the hydrophosphonate 
118. It is envisaged that a range of oligosaccharide conjugates can be prepared in this 
way and evaluated to determine the optimum size of the epitope required for activity. 
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4. EXPERIMENTAL 
Melting points were determined using a Reichert-lung Thermovar hot-stage microscope 
and are uncorrected. Optical rotations were determined on a Perkin-Elmer 141 
polarimeter in chloroform solutions and are recorded in units of 1O- l deg.Cm2.g- l . Infrared 
spectra were recorded using a Perkin-Elmer Paragon 1000 FT-IR spectrometer. 
All proton nuclear magnetic resonance eH-n.m.r) spectra were recorded unless otherwise 
specified, as deuteriochloroform sollJtions using tetramethylsilane as an internal standard 
on a Varian VXR-200 (200 MHz) or a Varian Mercury Spectrometer 300 MHz or a 
Varian Unity Spectrometer 400 MHz. Carbon 13 nuclear magnetic resonance (13C_n.m.r) 
spectra were recorded on the same instruments at 75 or 100 MHz using tetramethylsilane 
as an internal standard. 31 p n.m.r were also recorded in the same way using the same 
instruments. High-resolution mass spectrometry was performed at the mass-spectrometry 
unit of the Cape Technikon using a VG70-SEQ Micromass spectrometer. 
All reactions were monitored by TLC on aluminum-backed silica gel 60 F254 plates using 
an ascending technique. The plates were visualised by spraying with ceric ammonium 
sulfate in 8 M sulfuric acid or a 1: 1 solution of 5 % p-anisaldehyde in ethanol and 10 % 
sulfuric acid in ethanol baking at 200°C. Gravity column chromatography was done on 
Merck silicagel 60 (70 230 mesh). 
All the solvents used were dried by appropriate techniques9S,96 and all reactions were 
carried out under nitrogen or argon. All reagents were purchased from the chemical 
suppliers except for a, a-dimethoxytoluene,57 4-methoxybenzaldehyde dimethyl acetal,70 
and TEAB.97 
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BENZALDEHYDE DIMETHYL ACETAL 
A solution of benzaldehyde (lO.OmL, 98.4 mmol) and trimethyl orthoformate (12.4 mL, 
112.9 mmol) in dry methanol (50 mL) containing Amberlite IR - 120 (Hl ion exchange 
resin (500 mg; freshly washed with dry methanol) was refluxed for 3 h under nitrogen 
atmosphere. After TLC showed reaction was complete, the reaction mixture was cooled 
to room temperature, the resin was filtered off, and the filtrate evaporated at 30°C on a 
rotary evaporator. The residue was distilled under vacuum to afford the title compound in 
80 % yield; IH NMR (200 MHz, CDCh): 0 = 7.44 7.34 (m, 5 H, ArH), 5.40 (s, 1 H, H-
7), 3.34(s, 6 H, OCH3)' 
4-METHOXYBENZALDEHYDE DIMETHYL ACETAL 
A solution of 4-methoxybenzaldehyde (10.0 mL, 82.2 mmol), trimethyl orthoformate (9.9 
mL, 90.6 mmol) and p-toluenesulphonic acid monohydrate (780 mg, 0.042 mmol) was 
stirred at room temperature for 21 h. After TLC (ethyl acetate/petroleum ether 3 :7) 
showed completion of reaction, sodium carbonate (90 mg, 0.001 mmol) was added and 
stirred for an additional hour. The reaction mixture was then filtered and the formate 
distilled off with a rotary evaporator. The crude product was purified by distillation under 
reduced pressure to afford the title compound in 85% yield; IH NMR (200 MHz, CDCh): 
o 7.386 (d, 2 H, J 8.5 Hz, ArHa), 6.911 (d. 2 H, J= 8.5 Hz, ArHb), 5.369 (s, 1 H, H-
7),3.821 (s, 3 H, OMe), 3.327 (s, 6 20Me). 
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TETRAETHYLAMMONIUM BROMIDE (TEAB) 
AI: 1 mixture of triethylamine and ethyl bromide in acetone was refluxed overnight. The 
mixture was cooled to room temperature and the crystals were collected by filtration. 
Recrystalisation was carried out by dropwise addition of ethyl ether to a solution of 
TEAB in methanol; m.p 284 286°C (lit. 285°C). 
3,4,6-TRI-O-ACETYL-2-AZIDO-2-DEOXY-D-GLUCO-AND D-
MANNOPYRANOSYL NITRATES (38,39,40) 
A solution of tri-O-acetylglucal 7 (695 mg, 2.55 mmol) in dry acetonitrile (13 mL) was 
cooled to -20°C. To the solution at -20 °c was added sodium azide (250 mg, 3.85 mmol) 
followed by cerium(IV) ammonium nitrate (4.20 g, 7.66 mmol). The mixture was stirred 
vigorously while maintaining the temperature until TLC showed complete reaction (3 h). 
The mixture was diluted with ethyl acetate and washed with water until the organic layer 
was colorless, then with brine, dried with anhydrous magnesium sulphate, filtered and 
concentrated to syrup. The residue was purified by column chromatography to afford a 
mixture of the title compounds in 84 % total yield; R1 0.64 (ethyl acetate/petroleum ether 
1:1); IR O\faCl) Ymax: 2119 O\f3) em", 1670 (ON02) em-I" 1752 (C=O) cm- I; IH NMR 
(400 MHz, CDCh): 0 = 6.308 (d, 1 H, J',2 = 4.4 Hz, H-1 of compound 39),6.191 (d, 1 H, 
J,,2 2.0 Hz, H-l of compound 38),5.592 (d, 1 H, J',2 = 8.8 Hz, H-1 of compound 40), 
5.003 5.405 (m, 4 H), 4.047 - 4.318 (m, 6H), 3.668 (dd, 1 H, J 9.2 and 10.0 Hz), 
3.826 - 3.869 (m, 2 H); 13C NMR (100 MHz, CDCb) 0: 170.45, 170.35, 170.29, 169.70, 
169.61, 169.59, 169.44, 169.41, 169.23 (OAcs of compounds 38, 39, and 40), 97.72, 
97.12, 96.30 (C-ls of compounds 39, 38, and 40, respectively), 77.42, 77.00, 76.56, 
72.88,72.84,71.21,70.50,70.36,67.51,64.88,61.42,61.17, 61.06, 60.54,59.41,58.79 
(C-2, C-3, C-4, C-5, and C-6) 20.55, 20.52, 20.48, 20.41, 20.33 (OAc). 
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To a solution of the nitrates obtained above (38, 39 and 40) in acetonitrile (26 mL), 
thiophenol (0.8 mL, 7.79 mmol) and Hunig's base (0.4 mL, 2.30 mmol) were added. The 
reaction mixture was stirred under nitrogen. After 30 minutes TLC showed completion of 
reaction. The solvent was evaporated and the crude product subjected to column 
chromatography using ethyl acetate/petroluem ether mixture as eluant to give a mixture 
of 3,4,6-tri-O-acetyl-2-azido-2-deoxY-D-gluco- and D- mannopyranoses 41, 42, and 43 
in 84 % yield; Rf= 0.74 (ethyl acetate/petroleum ether 1:1); IHNMR (300 MHz, CDCh): 
8 = 5.000 (d, 0.25 H, J= 3.9 Hz, H-I), 4.901 (d,0.50 J= 1.2 Hz, H-1), 4.727 (d, 0.25 
H, J= 8.1 Hz, H-l); 13C 1\TMR (75 MHz, CDCh) selected data 8: 170.93,170.75,170.07, 
170.05,170.03, 169.77,169.67, 169.63, 169.52 (OAc), 92.87 (C-l), 92.74 (C-l), 92.09 
(C-l), 20.74, 20.69,20.66,20.63,20.57,20.52 (OAc). 
1,3,4, 6-TETRA-O-A CETYL-2-AZIDO-2-DEOXY-D-GLUCO- AND D-
MANNOPYRANOSES (44, 45, 46, and 47) 
a. To a solution of 3,4,6-tri-O-acetyl-2-azido-2-deoxy-manno and glucopyranoses 
41, 42, and 43 (500 mg, 0.54 mmol) in pyridine (5 mL) was added acetic 
anhydride (0.1 mL, 1.08 mmol) and DMAP (3.0 mg, 0.027 mmol). After stirring 
the mixture for 45 minutes at room temperature, TLC (ethyl acetate/petroleum 
ether 3:7) showed two new spots. The reaction mixture was then poured into 50 
mL of ice and water. The products were extracted with ethyl acetate and washed 
with brine, dried (magnesium sulphate), filtered, and concentrated. The residue 
was purified and resolved into the respective stereoisomers by column 
chromatography (ethyl acetate/petroleum ether 3:7) to afford peracetylated 2-
azido-2-deoxymannoses 44, 45 (combined yield ea 50 %), and peracetylated 2-
azido-2-deoxyglucoses 46, and 47 (ea 50 %). 
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b. Alternatively, a suspension of the syrup (38, 39,and 40) (2.13 g, 5.59 mmol) and 
sodium acetate (920 mg, 11.20 mmol) in acetic acid (14 mL) was heated to 100°C 
and the temperature maintained for 3 h. The reaction mixture was then cooled 
down to room temperature and diluted with dichloromethane. The mixture was 
successively washed with ice-cold water, saturated sodium bicarbonate, and 
water. The organic layer was then concentrated and purified by column 
chromatography to afford peracetylated 2-azido-2-deoxypyranoses 44, 45, 46 and 
47 in 98 %. 
Pure white crystal of peracetylated 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxY-D-
mannopyranoside 44 was obtained from the mixture by crystallization using ethanol and 
petroleum ether; m.p of 44 = 130°C; [a]D 20 of 44 = + 81.5; Rf 0.16 for 44 and 45 and 
0.26 for 46 and 47; IH NMR (400 MHz, CDCh) 44: 8 = 6.103 (d, 1 H, J1,2 = 2.0 Hz, H-
I), 5.408 - 5.339 (m, 2 H, H-3 and H-4), 4.232 (dd, 1 H, J = 4.8 Hz and 12.4 Hz, H-6a), 
4.086 (dd, 1 H, J = 2.4 Hz, and 12.4 Hz, H-6b), 4.018 (dd, 1 H, J1,2 2.0 Hz, J2,3 = 3.2 
H-2),4.012 3.880 (m, 1 H, H-5), 2.150 (s, 3 H, OAc), 2.102 (s, 3 H, OAc), 2.080 
(s, 3 H, OAc), 2.042 (s, 3 H, OAc); 13 C NMR (100 MHz, CDC h) 44: 8 = 170.625, 
169.988, 169.301, 168.114 (4 C=O), 91.380 (C-l), 70.770, 70.542, 65.352, 61.785, 
60.518 (C-2, C-3, C-4, C-5, and C-6), 20.808, 20.637, 20.539, 20.444 (OAc); IH NMR 
(400 MHz, CDCb) of 44 and 45 (70:30): 0 = 6.102 (d, 0.7 H, J 2.0 Hz, H-l), 5.811 (d, 
0.3 H, J = 1.5 Hz, H-l), 5.408 - 5.339 (m, 1.4 H, H-3, H-4), 5.268 (t, 0.3 H, J = 9.8 Hz, 
H-4), 5.043 (dd, 0.3 H, J = 3.7 Hz, 9.8 Hz, H-3), 4.232 (dd, 0.7 H, J 4.8 Hz, 12.4 Hz, 
H-6a), 4.214 (dd, 0.3 H, 4.7 Hz, 12.4 Hz, H-6a), 4.086 (dd, 0.7 H, J= 2.4 Hz, 12.4 Hz, H-
6b), 4.067 (dd, 0.3 H, J 2.2 Hz, 12.4 Hz, H-6b), 4.025 - 3.998 (m, 1 H, H-2, H-5), 
3.997 (dd, 0.7 H, J 2.0 Hz, 3.3 Hz, H-2), 3.704 (ddd, 0.3 H, J= 2.4 Hz, 4.8 Hz, 9.8 Hz, 
H-5), 2.161 (s, 0.9 H, OAc), 2.150 (s, 1 H, OAc), 2.102 (s, 3 H, OAc), 2.080 (s, 2.1 H, 
OAc), 2.065 (s, 0.9 H, OAc), 2.042 (s, 2.1 H, OAc), 2.024 (s, 0.9 H, OAc); IH NMR (400 
MHz, CDCh) 46 and 47 (40:60): 8 6.252 (d, 0.4 J1,2 3.7 Hz, H-l), 5.513 (d, 0.6 H, 
J 1,2 8.6 Hz, H-1), 5.420 (dd, 0.4 H, J= 9.4, 10.4 Hz, H-3), 5.101 - 4.904 (m, 1.6 H, H-
3, 2H-4), 4.244 (dd, 0.6 H, J= 4.6, 12.4 Hz, H-6a), 4.252 (dd, 0.4 H, J 4.2, 12.5 Hz, H-
6a), 4.040 (dd, 0.6 H, J 2.2, 12.4 Hz, H-6b), 4.121 - 3.978 (m, 0.8 H, H-5 and H-6b), 
3.761 (ddd, 0.6 H, J = 2.2,4.6,9.8 Hz, H-5), 3.619 (dd, 0.4 H, J 3.7, 10.4 Hz, H-2), 
3.616 (dd, 0.6 H, J 8.6,9.8 Hz, H-2), 2.153 (s, 1.2 H, OAc), 2.139 (s, 1.8 H,OAc), 
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2.057 (s, 1.2 H, OAc), 2.040 (s, 1.8 OAc), 2.029 (s, 3 H, 2 OAc), 2.001 (s, 1.2 H, 
OAc), 1.980 (s, 1.8 H, OAc). 
2-AZIDO-2-DEOXY-D-MANNOPYRANOSE (8) 
To a solution of peracetylated 2-azido-2-deoxymannoses 44 and 45 (1.30 g, 3.49 mmol) 
in dry methanol (60 mL) was added 2 mL of 0.3 M of freshly prepared sodium methoxide 
(in methanol) while stirring. The reaction mixture was stirred for 30 min at room 
temperature. After completion of reaction, a test drop from the mixture gave alkaline 
reaction to litmus. The sodium was removed by stirring with Amberlite IR 120 (H+) 
until the solution became neutral to litmus. The resin was then filtered and the solution 
concentrated to a syrup. The residue was purified by column chromatography 
(MeOHIethyl acetate 1:9) to afford 2-azido-2-deoxY-D-mannopyranose 8 in 90% yield; 
(mlz = 204.9) (lit. mlz 205.2)99; R/O.51 (MeOH/ethyl acetate 1:4); lH NMR (300 MHz, 
0 20): () = 5.204 (s, 0.5 H, la), 4.972 (d, 0.5 H, J1,2 = 1.5 Hz, H-1!3), 4.030 3.280 (m, 
6 H, H-2, H-3, H-4, H-5, H-6a, and H-6b) {lit. 5.05 (d, 0.64 H, J1,2 1.7 Hz, H-la), 4.81 
(d, 0.36 H, J1,2 = 1.5 H_l!3)}99; 13e NMR (75 MHz, 0 20): () = 92.97, 92.12, 76.32, 
72.50,72.35,70.11,66.81,66.55,65.92,64.38,60.80,60.68. 
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IvlETHYL 4, 6-0-BENZYLIDENE-a-D-GLUCOPYRANOSIDE (53) 
A solution of methyl a-D-glucopyranoside 52 (10 g, 51.49 mmol), benzaldehyde 
dimethyl acetal (7.73 mL, 51.60 mmol), in dry DMF (40 mL) containing 
p-toluenesulphonic acid monohydrate (26 mg, 0.14 mmol) was boiled under reflux for 2.5 
hrs. After 2 h, TLC (ethyl acetate/petroleum ether 2:3) showed the formation of a new 
spot, and the mixture was cooled down to room temperature, ice-cold saturated sodium 
hydrogen carbonate was added while stirring, extracted with ethyl acetate (3 x). The 
organic layer was washed with water, dried (anhydrous magnesium sulfate), filtered, and 
concentrated. The residue was purified by column chromatography (ethyl 
acetate/petroleum ether 2:3) to obtain 4,6-0-benzylidene acetal 53 in 80 % yield; m.p = 
164-166°C (lit. 163-164 0C)98; Rf O.28 (ethyl acetate/petroleum ether 1:1); [aJD 20 = 109. 
(lit. + 110 in chlorforml8; IH NMR (400 MHz, CDCh): S = 7.504 -7.354 (m, 5 H, ArlI), 
5.526 (s, 1 H, H-7), 4.784 (d, 1 H, J1,2 = 4.0 Hz, H-l), 4.288 (dd, 1 H, J5,6a = 4.4 Hz, J6a,6b 
9.6 Hz, H-6a), 3.920 (t, 1 H, J 9.2 Hz, H-3), 3.834 3.775 (m, 1 H, H-5), 3.734 (t, 
1 J 10.4 Hz, H-6b), 3.631 (bs, 1 H, H-2), 3.482 (t, 1 H, J = 9.6 Hz, H-4), 3.455 (s, 3 
H, OMe), 2.835 and 2.358 (2s, 2 H, 2 OlI); l3C NMR (l00 MHz, CDCh): 8 153.54, 
137.30,129.46,128.53,126.53 (Ar), 102.18 (C-7), 100.03 (C-l), 81.18 (C-4), 73.13 (C-
2),72.01 (C-3), 69.16 (C-6), 62.61 (C-5), 55.78 (OMe). 
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jl1ETHYL 2, 3-DI-O-ACETYL-4, 6-0-BENZYLIDENE-a-D-GLUCOPYRANOSIDE 
(56) 
To a solution of 4,6-0-benzylidene acetal 53 (100 mg, 0.29 mmol) and triethylamine 
(0.16 mL, 1.16 mmol) in dry dichloromethane (5 mL) were added acetic anhydride 
(0.27 mL, 2.90 mmol) and DMAP (2 mg, 0.02 mmol). After stirring for 40 min, the 
mixture was diluted with dichloromethane, washed with 10 % (w/v) aqueous sodium 
chloride, and the organic layer was dried (anhydrous magnesium sulfate), filtered, and 
concentrated. The residue was purified by column chromatography (ethyl 
acetate/petroleum ether 3:7) to give 56 (95 %); m.p 110°C (lit. 108-109 0C)98; [a]D 20 = 
+66.0 (lit. +75.5 in chloroform)98; IH NMR (400 1IIHz, CDCh): 0 = 7.504 7.338 (m, 5 
H, ArH), 5.582 (t, 1 H, J2,3 J3,4 = 9.6 Hz, H-3), 5.504 (s, 1 H, H-7), 4.942 (d, 1 H, J 1,2 = 
3.6 Hz, H-l), 4.908 (dd, 1 H, J1,2 3.6 Hz, J2,3 9.6 Hz, H-2), 4.303 (dd, 1 H, JS,6a = 
4.8 J6a,6b = 10.4 H-6a), 3.929 (sextet, 1 H, J4,s 9.6 Hz, JS,6a = 4.8 Hz, JS,6b = 10.4 
Hz, H-5), 3.768 (t, 1 H, J5,6b J6a,6b 10.4 Hz, H-6b), 3.647 (t, 1 H, J3,4 J4,5 = 9.6 Hz, 
H-4), 3.415 (s, 3 H, OMe), 2.090 and 2.050 (2s, 6 H, OAc); I3C NMR (l00 MHz, 
CDCh): 0 = 170.60, 169.97 (OAc), 153.54,137.19,129.27,128.42, 126,38 (Ar), 1Ol.82 
(C-7), 97.89 (C-l), 79.48 (C-4), 71.87 (C-2), 69.24 (C-3), 69.09 (C-6), 62.57 (C-5), 55.58 
(OMe), 20.00 and 20.94 (OAc). 
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METHYL 3-0-ACETYL-4, 6-0-BENZYLIDENE-a-D-GLUCOPYRANOSIDE (9) 
A mixture of 53 (1.00 g, 3.58 mmol) and sodium hydride (170 mg, 7.08 mmol) in dry 
THF (50 mL) was stirred at RT. After 2 h evolution of hydrogen ceased and anhydrous 
cupric chloride (477 mg, 3.54 mmol) was then added. After 10 min, a green solution that 
indicated formation of the copper chelate resulted. The reaction mixture was cooled down 
to 0 DC, acetic anhydride (0,50 mL, 540 mg, 5.31 mmol) was added dropwise, and the 
temperature was maintained at 0 °c for 30 min and then for l.5 h at room temperature. 
After adding water (2 mL) and acetic acid (1 mL), the reaction mixture was concentrated. 
The residue was diluted with dichloromethane, washed successively with water, aqueous 
sodium hydrogen carbonate, and saturated aqueous sodium chloride, dried (anhydrous 
magnesium sulfate), and concentrated. The solid residue was purified by column 
chromatography to yield monoacetylated glucoside 9 (80 %); Rf 0.85 (ethyl 
acetate/petroleum ether 2:3); m.p. 170-172 °c (lit. 174-175.5 °C)98; [aJD 200;;:: +74.0 (lit. 
+110 in chloroform)98; lH NMR (400 MHz, CDCh): (5 7.458 7.340 (m, 5 H, ArH), 
5.488 (s, 1 H, H-7), 5.321 (t, 1 H, J= 10.0 and 9.6 Hz, H-3), 4.800 (d, 1 H, = 4.0 Hz, 
1),4.299 (dd, 1 H, J6a,6b= 4.6 Hz, JS,6a = 10.2 Hz, H-6a), 3.865 (m, 1 H, H-2), 3.745 (t, 
1 J= 10.2 Hz, H-6b), 3.659 (m, 1 H, H-5), 3.578 (t, 1 H, Jo;;:: 9.6 Hz, H-4), 3.467 (s, 3 
H, OMe), 2.241 (d, 1 H, J= 11.2 Hz, OH), 2.116 (s, 3 H, OAc); 13CNMR (75 MHz, 
CDCh): 0 = 171.26 (OAc), 137.28, 129.27, 128.42, 126.41 (Ar), 101.77 (C-7), 100.38 
(C-l), 78.91 (CA), 72.56 (C-3), 72.12 (C-5), 69.14 (C-6), 62.99 (C-2), 55.78 (OMe), 
21 (OAc). 
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METHYL 3-0-ACETYL-2-AZIDO-4,6-0-BENZYLIDENE-2-DEOXY -a-D-
MANNOPYRANOSIDE (55) 
- 66-
To a cooled (0 0c) solution of monoacetylated glucoside 9 (380 mg, 1.18 mmol) in dry 
dichloromethane-pyridine (2:1, 12 mL) was added trifluo,romethanesu]phonic anhydride 
(0.50 mL, 3.07 mmol) at 0 °C and the mixture was stirred at 0 °C for 30 min. The solution 
was then diluted with dichloromethane, washed with saturated aqueous sodium hydrogen 
carbonate, dried (anhydrous magnesium sulfate), and concentrated to dryness. To a 
stirred solution of the crude product in DMF (13.00 mL) was added sodium azide (374 
mg, 5.75 mmol) and the mixture was kept at 70°C for 3 h, cooled down to room 
temperature, filtered through Celite, and concentrated, The residue was purified by 
column chromatography (ethyl acetate/petroleum ether I :9) to give azido mannoside 55 
in an over all yield of86 %; RfO.83 (ethyl acetate: petroleum ether 3:7); [aJD20 20.6; 'H 
NMR (300 MHz, CDCh) 8: 7.477 - 7.341 (m,5 H, ArH), 5.571 (s, 1 H, H-7), 5.432 (dd, 
1 H, J 3,2 = 3.9 J 3,4 10.2 Hz, H-3), 4.696 (d, 1 H, J \,2 = 1.5 Hz, H-l), 4.319 (dd, 1 
H, J 5,6a = 3.2 Hz, J6a,6b = 8.7 Hz, H-6a), 4.157 (dd, 1 H, J 1,2 = l.5 Hz, = 3.9 Hz, 
2),4.068 (t, 1 H, J = 9.0 and 10.2 Hz, H-4), 3.935 3.794 (m, 2 H, H-5, H-6b), 3.404 (s, 
3 H, OMe), 2.130 (s, 3 H, OAc); 13CNMR (75 MHz, CDCh): 8 170.00 (OAc), 137.09 
(C-Phq), 129.12, 128.24, 126.19 (C-Ph), 10l.99 (C-7), 99.91 (C-l), 76.03 (C-4), 70.22 
(C-3), 68.68 (C-6), 63.75 (C-5), 62.02 (C-2), 55.14 (OMe), 20.63 (OAc). 
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1,3,4,6-TETRA-O-ACETYL-2-AZIDO-2-DEOXY-D-MANNOPYRANOSES (44 
and 45) 
A solution of 55 (1.50 g, 4.33 mmol) in acetic anhydride (303 mL, 328 g, 3.22 mol) and 
acetic acid-sulfuric acid (41: 1 v/v, 31 mL) was stirred at room temperature. After 3 h, 
sodium hydrogen carbonate (powder) was added to the reaction mixture and cooled down 
to 0 0c. Methanol was added dropwise to the cooled reaction mixture and stirred for 
another 30 min, diluted with water and the product extracted with dichloromethane. The 
organic layer was dried (anhydrous magnesium sulfate), filtered, and concentrated. The 
crude solid product was purified by column chromatography (ethyl acetate/petroleum 
ether 3 :7) to afford 44 and 45 in a total yield of 87 %. 
METHYL 3-0-ACETYL-2-AZIDO-6-0-BENZYL-2-DEOXY -a-D-
MANNOPYRANOSIDE (64) 
A solution of 55 (364 mg, 1.05 mmol) in dry freshly distilled THF (15 mL) containing 
3A molecular sieves was stirred at room temperature for 30 mm. 
Sodiumcyanoborohydride (793 mg, 12.62 mmol) was added to the solution and the 
mixture stirred for an additional 10 min. Diethyl ether saturated with hydrogen chloride 
was then added to the reaction mixture with a syringe until evolution of gas ceased. After 
10 min TLC showed completion of reaction. The mixture was diluted with 
dichloromethane and water, filtered with aid of Celite. The organic layer was washed 
with water followed by saturated sodium hydrogencarbonate, dried (anhydrous 
magnesium sulfate), and concentrated to a syrup. The crude residue was purified by 
column chromatography (ethyl acetate/petroleum ether 1:4) to afford a 75 % yield of the 
title compound 64; (mlz = 350.1); Rf 0.50 (ethyl acetate: petroleum ether 3 :7); [a Jo 20 = 
31.7; lH NMR (400 MHz, CDCb): [) 7.350 7.258 (m, 5 H, ArH), 5.211 (dd, 1 H, J 
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4.0 Hz, 9.6 Hz, H-3), 4.684 (d, 1 H, J= 1.6 H-1), 4.602 (ABq, 2 H, J 11.6 Hz, 26.4 
Hz, PhCH2), 3.999 (dd, 1 H, J = l.6 Hz, J 4.0 H-2), 3.999 (m, 1 H, H-4), 3.753 (m, 
3 H, H-5, H-6a, H-6b), 3.375 (s, 3 H, OMe), 2.814 (bs, 1 H, OH), 2.149 (s, 3 H, OAc); 
13CNMR (100 MHz, CDCh): () = 171.04, (OAc), 138.00, 128.67, 128.02, 127.92 (Ar) , 
99.25 (C-l), 73.96 (PhCI-h, C-3), 7l.12 (C-5), 70.39 (C-6), 67.36 (C-4), 6l.54 (C-2), 
55.30 (OMe), 20.06 (OAc). 
METHYL 3, 4-DI-O-ACETYL-2-AZIDO-6-0-BENZYL-2-DEOXY--a-D-
MANNOPYRANOSIDE (65) 
To a solution of 64 (50 mg, 0.14 mmol) and triethyl amine (0.077 mL, 0.56 mmol) in dry 
dichloromethane (2 mL ) were added acetic anhydride (0.13 mL, 1.40 mmol) and DMAP 
(0.86 mg, 0.007 mmol). After stirring for 40 min, the mixture was diluted with 
dichloromethane, washed with 10 % (w/v) aqueous sodium chloride, and the organic 
layer was dried (anhydrous magnesium sulfate), filtered, and concentrated. The residue 
was purified by column chromatography (ethyl acetate/petroleum ether 3:7) to give the 
title compound (90 %); (mlz = 392.6); Rf O.67 (ethyl acetate/petroleum ether 3:7); [a]D 20 
= 72.9; NMR (400 MHz, CDCh): () 7.323 -7.310 (m, 5 H, ArH), 5.356 (dd, 1 H, 
J2,3 3.6 J3,4 9.6 Hz, H-3), 5.307 (t, 1 H, J = 9.6 Hz, H-4), 4.724 (d, 1 H, J1,2 = 1.6 
Hz, H-l), 4.541 (ABq, 2 H, J= 12.0 24.8 Hz, PhCH2), 4.002 (dd, 1 H, J1,2 = l.6 Hz, 
J2,3 = 3.6 H-2), 3.870 (ddd, 1 H, J 4.0 Hz, 4.8 Hz, 4.4 Hz, H-5), 3.551 3.534 (m, 2 
H, H-6a, H-6b), 3.396 (s, 3 H, OMe), 2.074 (s, 3 H, OAc), 1.908 (s, 3 H, OAc); 13CNMR 
(l00 MHz, CDCh): () = 169.93, 169.52 (OAc), 137.80, 128.25, 127.72, 127.56 (Ar) , 
98.80 (C-1), 73.50 (PhCH2), 7l.12 (C-3), 69.62 (C-5), 68.93 (C-6), 66.76 (C-4), 61.52 
(C-2), 55.08 COMe), 20.45 (OAc), 20.44 (OAc). 
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2-AZIDO-2-DEOXY-4,6-0-(4-METHOXYBENZYLIDENE)-D-
MANNOPYRANOSE (82) 
- 69-
A solution of 8 (74 mg, 0.36 mmol) and 4-methoxybenzaldehyde dimethyl acetal (0.010 
mL, 0.54 mmol) in dry DMF (4 mL) containing catalytic amount of p-toluenesulphonic 
acid monohydrate was boiled under reflux for 2.5 h. TLC showed the formation of a new 
spot, and the mixture was cooled down to room temperature, ice-cold saturated sodium 
hydrogen carbonate was added while stirring, extracted with ethyl acetate (3 x). The 
organic layer was washed with water, dried (anhydrous magnesium sulfate), filtered, and 
concentrated. The residue was purified by column chromatography (ethyl 
acetate/petroleum ether 2:3) to obtain 82 in 70 % yield; (mlz 322.9); RJ 0.19 (ethyl 
acetate/petroleum ether 2:3); IH NMR (300 MHz, CDCh) (a,:~, 2:1): b = 7.422 - 7.382 
(m, 2 H, ArHa), 6.896 (d, 2 H, J= 8.1 ArHb), 5.530 (s, 0.67 H, H-7), 5.503 (s, 0.33 H, 
H-7), 5.484 (d, 0.67 H, J = 2.7 Hz, H-l), 5.289 (d, 0.33 H, J 1.2 Hz, 1),4.343 
3.720 (m, 9 H, H-2, H-3, H-4, H-5, H-6a, H-6b, OMe); l3C NMR (l00 MHz, CDCb): b 
160.61, 160.56, 132.26, 129.78, 129.57, 127.82, 127.79, 114.57, 114.00 (Ar), 102.46, 
102.38 (C-7), 94.11, 93.73 (C-l), 79.26, 78.43,71.69,68.88,68.76,68.61,68.53,67.12, 
65.82,64.14,63.76 (C-3, C-5, C-6, C-4, C-2), 55.79, 55.55 (OMe). 
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1,3-DI-O-ACETYL-2-AZIDO-2-DEOXY -4,6-0-( 4-METHOXYBENZYLIDENE)-D-
MANNOPYRANOSE (83) 
To a solution of 82 (385 mg, 1.20 mmol) in dry dichloromethane (5 mL) and 
triethylamine (0.7 mL, 5.0 mmol) were added acetic anhydride (1.2 mL, 12.72 mmol) and 
DMAP (8 mg, 0.065 mmol). After stirring for 40 min, the mixture was diluted with 
dichloromethane, washed with 10 % (w/v) aqueous sodium chloride, and the organic 
layer was dried (anhydrous magnesium sulfate), filtered, and concentrated. The residue 
was purified by column chromatography (ethyl acetate/petroleum ether 3:7) to give 83 in 
80 % yield; (mlz 406.7); Rf 0.56 (ethyl acetate/petroleum ether 3:7); IH NMR (300 
MHz, CDCh) (a:p, 43:57) 0 = 7.391 - 7.349 (m, 2 H, ArHa), 6.896 - 6.863 (m, 2 H, 
ArHb), 6.061 (d, 0.43 H, J 1.8 Hz, H-l), 5.896 (d, 0.57 H, J= 1.5 H, H-l), 5.531 (s, 
0.43 H, H-7), 5.496 (s, 0.57 H, H-7), 5.437 (dd, 0.43 H, J 3.6 Hz, J= 10.2 H-3), 
5.133 (dd, 0.57 H, J 3.8 Hz, 10.4 Hz, H-3), 4.340 3.525 (m, 8 H, H-2, H-4, H-
6a, H-6b, OMe), 2.176 (s, 1.71 H, OAc), 2.164 (s, 1.29 H, OAc), 2.140 (s, 3 H, OAc); 
13CNMR (100 MHz, CDCh): 0 = 170.36,168.63,168.43 (OAc), 160.51, 129.58, 129.49, 
127.74, 113.90 (Ar), 102.23 (C-7), 92.25 (C-IP), 91.86 (C-la), 75.63, 75.17, 71.30, 
70.08, 68.52, 68.35, 68.28, 66.31, 62.00, 61.33 (C-2, C-4, C-5, C-6), 55.49 COMe), 
21.07,20.87,20.79 (OAc). 
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1,3-DI-O-ACETYL-2-AZIDO-2-DEOXY-6-0-(4-METHOXYBENZYL)-D-
MANNOPYRANOSE (84) 
- 71-
A mixture of83 (405 mg, 99.51 mmol), sodium cyanoborohydride (314 mg, 5.00 mmol), 
and 3A molecular sieves in DMF (8 mL) was stirred for 30 min at room temperature. A 
solution oftrifluoroacetic acid (0.77 mL, 10 mmol) in DMF (6 mL) was added dropwise 
at O°C to the stirring reaction mixture. When TLC (ethyl acetate/petroleum ether 2:3) 
after 2 h showed completion of reaction, the mixture was diluted with dichloromethane 
and water, and filtered with the aid of Celite. The organic layer was washed successively 
with water, saturated aqueous sodium hydrogen carbonate, dried (anhydrous magnesium 
sulfate), and concentrated to a syrup. The crude residue was purified by column 
chromatography to give 84 in 70 % yield; (mlz 409.2); Rf O.22 (ethyl acetate/petroleum 
ether 2:3); IH NMR (300 MHz, CDCh) (a:p, 45:55): 0 = 7.244 (d, 2 H, J 7.5 Hz, ArH), 
6.877 (d, 2 H, J = 8.7 Hz, ArH), 6.058 (d, 0.45 H, J1,2 2.1 Hz, ), 5.793 (d, 0.55 H, 
J1,2 = 1.2 H-1), 5.236 (dd, 0.45 H, J2,3 = 3.6 Hz, J3,4 9.6 Hz, H-3), 4.914 (dd, 0.55 
H, = 3.6 Hz, J3,4 = 9.6 Hz, H-3), 4.513 (ABq, 2 H, J= 11.4 and 24.3 Hz, CH2Ph), 
4.102 (dt, 0.45 H, J4,OH = 3.0 Hz, J3,4 = J4,5 = 9.6 Hz, H-4), 4.012 (dd, 0.45 H, J1,2 = 2.1 
Hz, J2,3 3.6 Hz, H-2), 3.987 (dt, 0.55 H, J4,OH = 3.0 Hz, J3,4 = J4,5 9.6 Hz, H-4), 3.881 
3.622 (m, 2.45 H, H-5, H-6a, H-6b), 3.802 (s, 3 H, OMe), 3.565 (m, 0.55 H, H-5), 
2.856 (d, 1 H, J4,OH = 3.3 Hz, OH), 2.176 (s, 1.6 H, OAc), 2.159 (s, 3 H, OAc), 2.135 (s, 
1.35 H, OAc); 13CNMR (l00 MHz, CDCh): 0 = 170.07, 169.45, 168.43 (OAc), 159.32, 
129.79, 129.72, 129.57, 113.77 (Ar), 91.35, 91.25 (C-1s), 75.01, 73.19, 72.06, 7l.64, 
70.41,68.34,68.19,66.26,65.85,61.17,60.89,55.26 (OMe), 20.84,20.77,20.63 (OAc). 
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1,3,4-TRI-O-ACETYL-2-AZIDO-2-DEOXY-6-0-(4-METHOXYBENZYL)-D-
MANNOPYRANOSE (85) 
-72-
To a solution of 84 (134 mg, 0.33 mmol) in dry dichloromethane (5 ml) and triethylamine 
(0.18 ml, 1.31 mmol) were added acetic anhydride (0.31 ml, 3.28 mmol) and DMAP (2 
mg, 0.02 mmol). After stirring for 40 min, the mixture was diluted with dichloromethane, 
washed with 10 % (w/v) aqueous sodium chloride, and the organic layer was dried 
(anhydrous magnesium sulfate), filtered, and concentrated. The residue was purified by 
column chromatography (ethyl acetate/petroleum ether 3:7) to give 85 in 85 % yield; (mlz 
450.6); R/ 0.48 (ethyl acetate/petroleum ether, 2:3); IH NMR (300 MHz, CDCh) (a:~, 
67:33): 8 = 7.210 (d, 2 H, J= 8.6 Hz, ArHa), 6.843 (d, 2 H, J= 8.6 Hz, ArHb), 6.090 (d, 
0.67 H, J1,2 = 2.1 Hz, H-l), 5.806 (d, 0.33 H, J1,2 1.5 Hz, H-l), 5.389 (t, 1 H, J= 9.6 
Hz, H-4), 5.296 (dd, 0.67 H, J2,3 = 3.6 Hz, J3,4 = 9.6 Hz, H-3), 5.041 (dd, 0.33 J2,3 = 
3.6 Hz, J3,4 9.6 Hz, H-3), 4.433 (ABq, 2 H, J = 11.5 Hz, 12.0 Hz, PhCH2), 4.119 (dd, 
0.33 H, J1,2 = 1.5 Hz, J2,3 = 3.8 Hz, H-2), 4.009 (dd, 0.67 H, J1,2 = 2.1 Hz, J2,3 = 3.4 
H-2), 3.973 - 3.916 (m, 0.67 H, H-5), 3.773 (s, 3 H, OMe), 3.693 3.634 (m, 0.33 H, H-
5) 3.505 (dd, 2 H, J= 4.1 Hz, J= 7.9 Hz, H-6a and H-6b), 2.155 (s, 0.99 H, OAc), 2.124 
(s, 2.01 H, OAc), 2.085 (s, 3 H, OAc), 1.908 (s, 2.01 H, OAc), 1.890 (s, 0.99 H, OAc); 
I3CNMR (75 MHz, CDCh): 8 170.01, 169.34, 168.24 (OAc), 159.24, 129.66, 129.54, 
129.50,113.68 (C-Ar), 91.36 (C-la), 91.26 (C-l~), 74.55 (C-5~), 73.17 (CI-{zPh), 72.07 
(C-5a), 71.94 (C-3~), 70.61 (C-3a), 68.35 (C-6a), 68.20 (C-6~), 66.34 (C-4a), 65.94 (C-
4~), 61.21 (C-2~), 60.54 (C-2a), 55.17 (OMe), 20.79, 20.62, 20.53, 20.46, 20.42 (OAc). 
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3,4-DI-O-ACETYL-2-AZIDO-2-DEOXY-6-0-(4-METHOXYBENZYL)-D-
MANNOPYRANOSE (86) 
-73-
To a stirred solution of 85 (140 mg, 0.31 mmol) in DMF (1 mL) at 50°C was added 
hydrazine acetate (34 mg, 0.37 mmol). After 10 min stirring at 50°C of the reaction 
mixture, TLC showed completion of reaction. The reaction mixture was then cooled 
down to room temperature and diluted with ethyl acetate. The organic layer was washed 
with 5% aqueous NaCI solution, dried (anhydrous magnesium sulfate), filtered, and 
concentrated. The crude product was purified by column chromatography (ethyl 
acetate/petroleum ether 3:7) to afford 86 in 82 % yield; (mlz = 408.8); Rf 0.34 (ethyl 
acetate: petroleum ether 2:3); IH N\!lR (300 MHz, CDCh) a/[3 0.67:0.33 (5 = 7.212 (d, 
2 H, 8.6 Hz, ArHa), 6.844 (d, 2 H, J 8.6 Hz, ArHb), 5.416 (dd, 0.67 H, 12,3 3.9 Hz, 
,h,4 9.6 Hz, H-3), 5.246 (t, 1 H, 9.8 Hz, H-4), 5.159 (d, 0.67 H, J1,2 = 1.6 Hz, H-l), 
5.008 (dd, 0.33 H,12,3 3.9 Hz, 13,4 = 9.6 Hz, H-3), 4.815 (s, 0.33 H, H-l), 4.503 - 4.436 
(m, 3 H, CH2Ph and OH), 4.059 - 4.169 (m, 1 H, H-5), 3.954 (dd, 0.67 H, J1,2 = 1.6 Hz, 
J2,3 = 3.8 Hz, H-2), 3.795 (s, 3 H, OCH3), 3.510 - 3.444 (m, 2 H, H-6a and H-6b), 2.102 
(s, 0.99 H, OAc), 2.085 (s, 2.01 H, OAc), 1.952 (s, 2.01 H, OAc), 1.921 (s, 0.99 H, OAc); 
13CNMR (l00 MHz, CDCh): (5 = 159.40, 129.86, 129.75, 129.72, 129.64, 113.86,93.54, 
92.79, 73.20, 72.16, 71.02, 70.89, 68.78, 68.46, 67.06, 66.82, 61.20, 60.67, 55.25,20.86, 
20.77,20.64. 
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3,4-DI-O-ACETYL-2-AZIDO-2-DEOXY-6-0-(4-METHOXYBENZYL)-D-
MANNOPYRANOSYL TRICHLOROACETIMIDATE (87) 
-74-
To a solution of 86 (75 mg, 0.183 mmol) in dry dichloromethane (2' mL) at room 
temperature were added trichloroacetonitrile (0.070 mL, 0.71 mmol) and dry finely 
powdered potassium carbonate (112 mg, 0.81 mmol). After 4 h, the reaction mixture was 
diluted with dichloromethane, filtered through Celite and concentrated to a syrup. The 
residue was purified by column chromatography (ethyl acetate/petroleum ether 1 :9) to 
obtain imidate 87 (65%); (mlz = 551.6); RfO.59 (ethyl acetate: petroleum, 2:3); IH NMR 
(400 MHz, CDCh): 8 = 8.741 (s, 1 H, NH), 7.206 (d, 2 H, J= 8.4 Hz, ArHa), 6.837 (d, 2 
H, J= 8.8 Hz, ArHb), 6.266 (d, 1 H, JJ,2 = 1.8 Hz, H-l), 5.457 (t, 1 H, J= 9.7 Hz, H-4), 
5.395 (dd, 1 H, J2,3 = 3.5 Hz, J3,4 = 9.7 Hz, H-3), 4.444 (ABq, 2 H, J 11.3 Hz, J 37.4 
Hz, PhCH2), 4.254 (dd, 1 H, J],2 = 1.8 Hz, J2,3 3.7 H-2), 4.111 - 4.068 (m, 1 H, 
H-5), 3.775 (s, 3 H, OMe), 3.524 (d, 2 H, J = 4.0 H-6a and H-6b), 2.087 (s, 3 H, 
OAc), 1.917 (s, 3 H, OAc); !3CNMR (100 MHz, CDCh): 8 170.08, 169.53 (OAc), 
160.09 (CNHCCh), 159.41, 129.91, 129.65, 113.87 (Ar) , 95.63 (C-l), 73.28 (CI-hPh), 
72.71 (C-5), 70.95 (C-3), 68.30 (C-6), 66.24 (C-4), 60.10 (C-2), 55.37 (OMe), 20.74, 
20.60 (OAc) 
2-AZIDO-4,6-0-BENZYLIDENE-2-DEOXY -D-MANNOPYRANOSE (90) 
A solution of 8 (103 mg, 0.50 mmol) and benzaldehyde dimethyl acetal (0.38 mL, 385 
mg, 2.50 mmol) in dry DMF (13 mL)containing p-toluenesulphonic acid monohydrate 
(250 mg,O.1 mmol) was stirred at room temperature for 3 h. TLC showed the formation 
of a new spot, and ice-cold saturated sodium hydrogen carbonate was then added while 
stirring, extracted with ethyl acetate (3 x). The organic layer was washed with water, 
dried (anhydrous magnesium sulfate), filtered, and concentrated. The residue was purifi.ed 
by column chromatography (ethyl acetate/petroleum ether 2:3) to obtain 90 (75 %); (m/z 
293.1); Rf O.63 (ethyl acetate: petroleum ether 2:3); IH NMR (400 MHz, CDCI 3) (a,:~, 
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0.67:0.33): 8 7.487 7.374 (m, 5 H, 2ArH), 5.580 (s, 0.67 H, H-7), 5.553 (s, 0.33 H, H-
7), 5.l78 (d, 0.67 H, J 1.6 Hz, H-l), 4.823 (d, 0.37 H, J= 1.6 1),4.359 - 3.3l3 
(m, 6 H, H-2, H-3, H-4, H-5, H-6a, H-6b), 2.865 (bs, 2 H, 20H); 13C NMR (75 MHz, 
CDCh): 8 = 137.03,129.42,129.35,128.41,128.38,126.25,126.21 CAr), 102.30, 102.21 
(C-7), 93.86 (C-IJ3), 93.49 (C-1a), 79.08, 78.26, 71.44,68.67,68.51,68.31,66.85,65.57, 
63.89,63.52 (C-3, C-5, C-6, C-4, and C-2, respectively). 
1,3-DI-O-ACETYL-2-AZIDO-4,6-0-BENZYLIDENE-2-DEOXY -D 
MANNOPYRANOSE (91) 
To a solution of 90 (l00 mg, 0.34 mmol) in dry dichloromethane (3 mL) and triethyl 
amine (0.2 mL, 0146 mg, 1.36 mmol) were added acetic anhydride (0.32 mL, 346 mg, 
3.40 mmol) and DMAP (2 mg, 0.017 mmol). After stirring for 40 min, the mixture was 
diluted with DCM, washed with 10 % (w/v) aqueous sodium chloride, and the organic 
layer was dried (anhydrous magnesium sulfate), filtered, and concentrated. The residue 
was purified by column chromatography (ethyl acetate/petroleum ether 3:7) to give 91 
(90%); (mlz 376.95); Rf 0.71 (ethyl acetate: petroleum ether 2:3); IH NMR (400 MHz, 
CDCb) (a:~, 50:50): 8 7.479 -7.157 (m, 5 H, ArH), 6.080 (d, 0.5 H, J1,2 = 1.6 Hz, H-
1),5.906 (d, 0.5 H, J1,2 1.6 Hz, H-l),5.586 (s, 1 H, H-7), 5.470 (dd, 0.5 H, h,3 = 3.6 Hz, 
J3,4 = 10.4 Hz, H-3), 5.151 (dd, 0.5 H, J 2,3 = 3.8 Hz, J 3,4 = 10.2 Hz, H-3), 4.342 (dd, 0.5 
H, J S,6a= 4.8 Hz, J6a,6b = 10.4 Hz, H-6a), 4.280 ( dd, 0.5 H, 4.8 Hz, J 6a,6b = 10.4 Hz, 
H-6a), 4.275 (dd, 0.5 H, J 1,2 1.6 Hz, J2,3 = 4.0 Hz, H-2), 4.169 4.119 (m, 1 H, H-2, H-
4),4.012 (t, 0.5 H, J 10.0 Hz, H-4), 3.980 (ddd, 0.5 H, 9.6 Hz, J6a,S = 4.8 Hz, J S,6b 
= 10.4 Hz, H-5), 3.831 (t, 0,5 H, J= 10.2 Hz, H-6b), 3.807 Ct, 0.5 H, J 10.4 Hz, H-6b), 
3.586 (ddd, 0.5 H, J 5,6a 4,8 Hz, J4,5 = 10.4 Hz, J S,6b 14.4 Hz, H-5), 2.184 (s, 1.5 H, 
OAc), 2.175 (s, 1.5 H, OAc), 2.159 (s, 1.5 H, OAc), 2.151 (s, 1.5 H, OAc); 13CNMR (100 
MHz, CDCl3): a 8 170.31, 168.62 (OAc), l37.10, 129.44, 129.40,129.25, 128.51, 
128.48 (Ar), 102.25 (C-7), 92.26 (C-1), 75.73 (C-4), 70.05 (C-3), 68.59 (C-6), 66.31 (C-
5),61.36 (C-2), 21.10, 20.80 (OAc); 13 CNMR (l00 MHz, CDCb): J3 8 = 170.34, 168.42 
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(OAc), 136.99, 129.46, 128.51, 126.40 (Ar), 102.26 (C-7), 91.86 (C-l), 75.24 (C-4), 
71.27 (C-3), 68.35 (C-6), 68.33 (C-5), 62.01 (C-2), 20.88,20.81 (C-OAc). 
1,3-DI-O-ACETYL-2-AZIDO-6-0-BENZYL-2-DEOXY -D-MANNOPYRANOSE 
(92) 
A solution of 91 (400 mg, 1.06 mmol) in dry freshly distilled THF (11 mL) containing 
3A molecular sieves was stirred at room temperature for 30 min. Sodium 
cyanoborohydride (0.73 g, 11.66 mmol) was added to the solution and the mixture stirred 
for an additional 10 min. Diethyl ether saturated with hydrogen chloride was then added 
to the reaction mixture with a syringe until evolution of gas ceased. After 10 min, TLC 
(ethyl acetate/petroleum ether 2:3) showed completion of reaction. The mixture was 
diluted with dichloromethane and water, filtered with aid of Celite. The organic layer was 
washed with water followed by saturated sodium bicarbonate, dried (anhydrous 
magnesium sulfate), and concentrated to a syrup. The crude residue was purified by 
column chromatography (ethyl acetate/petroleum ether 3:7) to afford 92 (65 %); (m/z 
378.9); RfO.66 (ethyl acetate: petroleum, 2:3); IH NMR (300 MHz, CDCb): (a:(3, 60:40) 
(5 7.350 - 7.298 (m, 5 H, ArH), 6.068 (d, 0.6 H, J1•2 = 1.8 Hz, H-l), 5.802 (d, 0.4 H, 
J1,2 1.2 H-l), 5.239 (dd, 0.6 H, 3.6 Hz, J3,4 = 9.6 Hz, H-3), 4.919 (dd, 0.4 H, 
J2,3 3.8 J3,4 9.6 Hz, H-3), 4.578 (ABq, 2 H, J = 12.0 and 11.7 PhCH2),4.131 
(dd,O.4 J],2 = 1.2 Hz, J 2,3 = 3.8 Hz, 4.026 - 3.545 (m, 4 H, H-4, H-6a, H-
6b), 3.414 (ddd, 0.6 H, J4•5 = 9.6 Hz, JS,6 4.8 Hz, H-5), 2.896 (bs, 1 OH), 2.174 (s, 
1.2 H, OAc), 2.169 (s, 1.2 H, OAc), 159 (s, 1.2 H, OAc), 2.134 (s, 1.8 H, OAc); l3C 
NMR (75 MHz, CDCh): (5 170.88, 170.53, 168.43 (OAc), 137.32 (Arq), 128.50, 
128.47,127.97, 127.93, 127.86, 127.82 (Ar), 91.58 (C-la), 91.41 (C-l(3), 75.07,74.29, 
73.85,70.00,69.90,66.87,66.69,61.04,59.37 (C-3, CH2Ph, C-5, C-6, C-4, C-2), 20.88, 
20.71,20.67 (OAc). 
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1,3,4-TRI-O-ACETYL-2-AZIDO-6-0-BENZYL-2-DEOXY-n-MANNOPYRANOSE 
(93) 
To a solution of 92 (60 mg, 0.16 mmol) in dry dichloromethane (0.5 mL) and triethyl 
amine (0.09 mL, 0.65 mmol) were added acetic anhydride (0.15 mL, 1.58 mmol) and 
DMAP (0.001 gm, 0.008 mmol). After stirring for 40 min, the mixture was diluted with 
dichloromethane, washed with 10 % (w/v) aqueous sodium chloride, dried (anhydrous 
magnesium sulfate), filtered, and concentrated. The residue was purified by column 
chromatography (ethyl acetate/petroleum ether 3:7) to 93 (85 %); (mlz = 420.8); Rj 
0.75 (ethyl acetate/petroleum ether 2:3); lH NMR (400 MHz, CDCb) (a:~, 80:20): 0 
6.070 (d, 0.8 H, J 1,2 = 2.0 H-1), 5.802 (d, 0.2 H, J 1,2 1.2 Hz, H-1), 5.381 (t,O.2 
J 3,4 J 4,s = 9.6 Hz, H-4), 5.049 (dd, 0.2 H, J2,3 = 3.8 Hz, J 3,4 9.6 Hz, H-3), 5.233 (t, 0.8 
H, J 3,4 J4,S = 9.6 Hz, H-4), 5.329 (dd, 0.8 H, J 2,3 = 3.4 J3,4 9.6 Hz, H-3), 4.529 
4.417 (m, 2 H, CH2Ph), 4.101 (dd, 0.2 H, Jl,2 = 1.6 Hz, J2,3 3.6 Hz, H-2), 3.995 (dd, 0.8 
J 1,2 2.0 Hz, J 2,3 = 3.6 Hz, H-2), 4.005 3.920 (m, 1 H, H-6a), 3.665 (ddd, 1 H, J 4,s 
9.6 Hz, JS,6a = 4.4 Hz, JS,6b = 3.6, H-5), 3.60 - 3.454 (m, 1 H-6b), 2.120 (s, 0.6 H, 
OAc), 2.091 (s, 2.4 H, OAc), 2.050 (s, 0.6 H, OAc), 2.046 (s, 2.4 H, OAc), 1.88 (s, 2.4 
H, OA), 1.862 (s, 0.6 H, OAc); 13CNMR (100 MHz, CDCh): 0 170.09,170.04,169.37, 
168.41,168.31, (OAc), 137.66,137.60 (Ar), 128.34,128.32,127.98,127.94,127.72 (Ar), 
91.45 (C-1a), 91.33 (C-1~), 74.64, 73.66, 73.61, 72.03, 70.68, 68.71, 68.57,66.38,65.98 
(C-3, C-4, C-5, C-6), 61.27 (C-2a), 60.61 (C-2~), 20.88, 20.70, 20.61, 20.57, 20.54, 
20.49 (OAc). Un
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3,4-DI-O-ACETYL-2-AZIDO-6-0-BENZYL-2-DEOXY-n-MANNOPYRANOSE 
(66) 
To a solution of 93 (100 mg, 0.24 mmol) in DMF (3 mL) at 50°C was added hydrazine 
acetate (26 mg, 0.28 mmol). After 10 minutes stirring at 50°C of the reaction mixture, 
TLC showed completion of reaction. The mixture was then cooled to room temperature 
and diluted with ethyl acetate. The organic layer was washed with 5 % aqueous NaCI 
solution, dried (anhydrous magnesium sulfate), filtered, and concentrated. The crude 
product was purified by column chromatography (ethyl acetate/petroleum ether 3:7) to 
afford 80 % of 66; (mlz 379.1); Rf O.63 (ethyl acetate: petroleum ether 2:3); IH NMR 
(300 MHz, CDCh) (a:~, 60:40) 8: 7.370 -7.243 (m, 5 H, ArH), 5.412 (dd, 0.6 H, J2,3 = 
3.9 Hz, J3,4 = 9.6 Hz, H-3), 5.182 (t, 1 H, J 3,4 9.9 Hz, J 4,5 10.2 Hz, H-4), 5.134 (d, 0.6 
H, J 1,2 = 1.5 Hz, ),5.006 (dd, 0.4 H, J 2,3 = 3.9 Hz, J 3,4 = 9.9 Hz, H-3), 4.757 (bs, 0.4 H, 
H-1), 4.503 (ABq, 2 H, J 11.7 and 14.7 Hz, CH2Ph), 4.247 (bs, 1 H, OH), 4.140 (ddd, 1 
H, J 4,s 9.9 Hz, J S,6a 6.8 Hz, J S.6b 2.4 Hz, H-5), 3.910 (dd, 1 H, J1,2 1.8 Hz, J2,3 = 3.6 
Hz, H-2), 3.452 (dd, 1 H, J 6a,6b = 10.4 Hz, J S,6b 2.7 Hz, H-6b), 3.543 (dd, 1 H, J 6a,6b 
10.4 Hz, JS,6a 6.8 Hz, H-6a), 2.090 (s, 1.20 H, OAc) 2.074 (s, 1.80 H, OAc), 1.937 (s, 
1.80 H, OAc), 1.912 (s, 1.20 H, OAc); 13C NMR (75 MHz, CDCh) for a 8: 170.23, 
170.04 (OAc), 128.66, 128.42, 128.33, 128.17, 128.11 CAr), 92.68, 70.99, 69.58, 69.50, 
67.18,62.29 (C-l, 3, 5, 6, 4, and 2, respectively), 20.85 (OAc), 20.75 (OAc); l3C NMR 
(75 MHz, CDCb) for 13 8: 93.14, 72.87, 69.15, 66.62, 63.61 (C-l, 3, 6, 4, and 2, 
respectively), 20.69 (OAc). Un
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TRIETHYLAMMONIUM 3,4-DI-O-ACETYL-2-AZIDO-6-0-BENZYL-2-
DEOXY -a.-D-MANNOPYRAN OSYL HYDROPHOSPHONATE (118) 
- 79-
A solution of 66 (150 mg, 0.4 mmol) in dry dioxane (1.5 mL) and pyridine (0.5 mL) was 
treated with a solution of salicylchlorophosphite (1 mL, I.25M stock solution 
salicylchlorophosphite in dioxane) and stirred at room temperature for 20 minutes. The 
reaction was quenched with cold 0.5 M TEAB (aq) solution and stirred for additional 30 
minutes. The reaction mixture was evaporated to remove the dioxane. The residue was 
diluted with chloroform, washed successively with cold water and TEAB solution. The 
organic layer was concentrated and purified by column chromatography using 10 % 
MeOHICHCh/Et3N solvent system to yield 50 % of hydrophosphonate 118; Rf 0.44 
(MeOHIchloroform and a drop of triethyl amine 1:4); IH NMR (300 MHz, CDCh): 15 = 
7.258 7.237 (m, 5 H, ArH), 6.949 (d, 1 Jp,H = 647.1 hz, PH), 5.622 (dd, 1 H, J1,p 
8.4 Hz, J 1,2 1.2 Hz, H-1), 5.426 (dd, 1 H, J 2,3 3.6 Hz, J 3,4 9.9 Hz, H-3), 5.313 (t, 1 
H, J= 9.9 Hz, H-4), 4.446 (ABq, 2 H, J= 12.0 Hz, 24.6 Hz, PhCH2), 4.158 -4.087 (m, 3 
H, H-5, H-6a, H-6b), 3.470 (d, 1 H, J2,3 3.6 Hz, H-2), 3.052 (q, 2 H, J 7.2 Hz, 14.4 
Hz, CH3CH2), 2.012 (s, 3 OAc), 1.849 (s, 3 H, OAc), 1.309 (t, 3 J = 7.2 Hz, 
CH3CHz); I3C NMR (75 MHz, CDCb): 15 = 169.79, 169.46 (OAc), 137.70, 128.11, 
127.74, 127.43 (Ar), 92.99 (C-1), 73.29 (PhClh), 70.67,70.56,68.64,66.52,62.26 (C-2, 
C-3, C-4, C-5, C-6), 45.76 (Et3N), 20.47 (OAc), 20.37 (OAc), 8.45 (Et3N); 31p (300 
MHz, CDCb): 15 = - 0.82. 
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